TSS:Rfhg 60000.1

Basic information about the TSS

---

TSS ID: rfhg_60000.1 Species: human Chr: chr4		Start: 87007745 End: 87007750 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AB385236:-337 GeneID: 4299 HGNC/MGI_ID: HGNC:7135 UniProt_ID: Nearer transcript ids and distances:

Gene_name: AFF1 Gene_symbol: AFF1 Gene_synonyms: AF-4 AF4 FEL Gene_source: HGNC:7135

TATA-Box annotation

---

Distance to TSS:	746
Nearest PromoterID:	NM_005935
Entrez ID:	4299
Nearest Unigene:	Hs.480190
Nearest Refseq:	NM_005935
Nearest Ensembl:	ENSG00000172493
Gene Name:	AFF1
Gene Alias:	AF4|MLLT2|PBM1
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.166667
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@AFF1 p2@AFF1 p3@AFF1 p4@AFF1 p5@AFF1 p7@AFF1 p9@AFF1 p10@AFF1
Sample		p1@AFF1	p2@AFF1	p3@AFF1	p4@AFF1	p5@AFF1	p7@AFF1	p9@AFF1	p10@AFF1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	8.18	3.90	4.29	3.12	3.12	0.58	0.39	0.97
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	8.09	2.43	5.66	2.43	3.03	0.40	0.40	1.42
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	7.14	3.28	3.67	2.31	3.47	0.96	0.77	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	4.78	2.08	4.37	2.29	3.74	0.83	0.42	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	5.40	4.05	4.27	2.70	4.27	0.90	0.00	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	4.85	3.88	4.46	2.91	4.65	2.33	0.39	1.16
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	4.58	3.49	4.36	2.18	3.27	0.87	0.87	1.53
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	6.78	3.63	2.91	1.21	3.63	0.73	0.24	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	6.20	2.56	3.21	1.07	2.78	1.07	1.07	1.28
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	7.54	7.54	5.22	2.90	4.06	0.58	0.58	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	8.49	7.28	6.06	4.04	4.45	1.62	0.81	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	6.50	5.69	3.25	5.29	3.25	1.63	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	8.22	2.90	9.03	3.71	1.93	0.32	0.64	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	3.46	3.31	7.37	5.71	1.50	0.75	1.20	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	7.46	3.07	5.93	2.42	1.98	0.66	1.10	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	3.77	2.51	6.54	2.26	1.01	0.75	0.25	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	5.24	3.71	5.68	2.84	1.31	0.22	1.09	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	5.06	3.37	2.11	3.37	2.53	0.84	1.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	2.67	2.13	4.80	1.07	0.00	1.07	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	4.06	2.71	5.87	3.16	0.90	0.45	0.60	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	7.75	3.07	6.28	3.88	1.60	0.13	1.07	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	4.32	1.73	6.04	3.11	1.21	0.35	0.35	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	5.69	3.62	5.30	2.33	1.68	0.52	1.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	3.40	0.97	5.58	2.43	0.24	0.24	0.49	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	2.32	0.77	5.42	2.06	1.55	0.00	0.77	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	4.43	1.58	2.85	1.27	1.90	0.00	0.95	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	6.04	1.10	4.40	2.75	1.65	0.00	2.75	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	6.37	2.83	6.84	3.54	1.41	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	4.68	1.94	4.20	2.42	0.97	0.16	0.32	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	5.07	2.35	5.07	0.90	0.90	0.72	1.27	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	2.93	3.14	4.81	2.72	0.84	0.21	0.63	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	3.32	1.37	4.69	1.95	0.98	0.20	0.00	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	3.59	1.48	5.70	1.69	0.84	0.42	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	2.97	2.31	5.44	2.14	1.15	0.49	1.15	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	2.80	1.87	3.93	1.68	1.12	0.56	0.56	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	2.87	1.92	7.09	3.07	0.19	0.00	0.38	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	2.66	0.82	4.70	4.09	0.82	0.20	0.82	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	3.43	0.81	4.84	2.42	1.41	0.20	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	3.78	1.08	5.67	2.97	0.27	0.27	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	2.64	2.64	4.32	2.16	0.96	0.48	0.96	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	3.06	1.18	5.41	2.35	1.41	0.47	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	2.64	1.76	5.42	2.49	2.34	0.73	0.59	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	2.53	0.63	6.33	2.53	1.05	0.42	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	3.32	0.70	5.24	2.80	1.57	0.87	0.52	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	3.41	1.20	9.44	3.61	0.60	1.00	0.40	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	3.72	1.16	5.12	3.02	0.70	0.23	1.40	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	4.56	0.24	5.52	2.64	1.20	0.48	0.96	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	3.58	0.60	4.17	2.98	1.79	0.89	0.60	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	6.46	1.68	6.46	3.11	1.44	0.96	0.96	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	4.65	2.22	4.85	4.25	2.22	0.20	1.42	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	5.33	3.69	6.56	2.46	1.43	0.61	1.23	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	6.45	2.00	6.00	3.56	2.22	1.11	1.56	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	0.00	27.98	0.00	0.00	13.99	13.99	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	4.97	3.90	5.68	2.48	2.84	1.42	0.71	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	9.61	2.98	5.30	1.66	2.32	0.66	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	6.71	4.19	11.75	3.36	2.52	4.19	12.58	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	9.64	4.59	5.05	2.76	2.76	0.92	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	7.78	1.94	8.43	4.21	2.27	0.00	0.97	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	8.67	0.64	5.14	3.53	1.28	0.32	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	5.34	2.20	7.23	3.77	1.57	0.63	2.20	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	11.99	2.12	2.12	4.23	2.12	1.41	2.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	6.17	2.80	5.05	2.80	2.80	0.56	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	18.31	3.98	5.57	5.57	0.80	3.18	14.33	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	7.81	1.70	5.78	1.70	3.40	1.36	2.04	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	10.07	0.65	5.20	6.82	1.62	0.32	1.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	8.16	3.55	3.19	1.06	1.06	0.71	1.77	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	0.00	0.00	0.00	0.00	0.00	16.16	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	31.59	15.79	7.90	7.90	0.00	0.00	31.59	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	8.78	3.41	2.44	2.93	1.46	0.00	0.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	17.85	3.97	1.98	1.98	1.49	0.50	1.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	7.51	1.88	1.41	1.88	0.94	0.00	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	8.28	2.65	2.65	2.98	1.32	0.33	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	10.83	5.26	2.78	2.17	2.17	0.00	1.24	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	12.84	4.89	3.67	4.28	2.75	0.61	1.22	0.00
Adipocyte - breast, donor1	11376-118A8	12.83	7.13	3.80	3.17	4.28	0.63	0.16	0.32
Adipocyte - breast, donor2	11327-117E4	12.99	5.13	4.17	5.13	2.73	0.00	0.32	0.16
Adipocyte - omental, donor1	11473-119C6	21.50	11.07	3.31	5.34	7.51	0.51	0.38	0.38
Adipocyte - omental, donor2	11474-119C7	5.98	5.98	5.23	0.75	2.99	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	8.37	4.69	6.03	1.00	1.00	0.00	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	11.48	1.91	2.55	2.55	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	2.20	1.10	1.10	1.10	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	7.23	1.81	1.81	1.35	0.90	0.45	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	3.65	1.39	0.70	2.09	0.87	0.00	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	26.60	7.04	1.76	2.74	2.15	0.98	0.98	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	23.42	7.21	1.29	3.35	0.51	0.77	0.77	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	22.86	6.69	3.35	1.95	0.84	2.51	1.39	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	21.16	3.53	1.18	1.18	1.76	0.59	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	15.12	7.72	3.54	6.03	2.49	2.01	0.97	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	20.01	8.71	1.29	3.87	0.00	1.94	0.97	0.97
Adipocyte differentiation, day08, donor3	13026-139E2	10.66	3.73	0.53	1.60	1.60	0.00	1.60	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	12.24	7.23	2.78	2.23	3.34	0.56	1.11	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	6.24	2.50	4.57	4.57	0.42	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	14.57	8.79	1.76	1.76	1.26	2.01	0.50	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	14.73	7.20	1.96	3.60	1.64	0.98	0.33	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	10.66	3.96	3.96	4.57	0.61	0.30	1.22	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	15.91	5.97	3.31	3.09	1.77	3.54	0.22	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	7.53	3.59	1.08	0.72	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	2.40	1.20	2.40	2.40	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	20.33	6.48	4.14	3.06	2.70	1.44	1.98	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	10.04	1.67	1.67	5.02	0.00	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	11.51	3.08	2.88	3.90	1.64	0.21	1.03	0.00
Anulus Pulposus Cell, donor1	11248-116E6	5.84	3.32	1.60	2.63	1.72	0.00	0.00	0.00
Anulus Pulposus Cell, donor2	11463-119B5	7.35	2.45	1.22	3.92	1.22	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	4.49	2.70	2.25	3.15	0.45	0.90	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	1.74	1.74	2.17	0.87	1.30	0.43	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	4.28	0.00	2.14	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	3.59	1.49	1.20	0.60	2.09	0.00	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	10.12	0.00	0.00	2.53	0.00	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	4.62	0.00	1.32	0.66	0.00	0.66	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	7.15	1.62	3.25	0.32	0.65	0.32	1.62	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	3.88	1.94	0.49	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	4.16	1.78	1.78	0.59	1.19	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	5.65	1.88	2.26	1.88	0.38	0.00	1.13	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	0.73	2.90	2.18	0.73	1.45	0.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	2.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	5.27	2.64	0.66	0.82	0.82	0.33	0.00	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	4.09	5.46	1.36	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	3.47	1.66	0.60	1.21	0.30	0.45	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	3.75	3.75	2.14	1.61	1.07	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	5.67	2.65	1.51	0.94	0.76	0.19	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	3.74	2.94	1.34	1.34	0.80	0.80	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	7.80	2.93	3.90	0.98	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	4.81	1.66	1.66	0.50	0.50	0.66	0.17	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	2.40	1.20	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	0.00	3.54	0.00	0.00	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	4.46	1.89	2.92	1.37	0.69	0.34	0.34	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	8.39	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	5.34	1.46	1.94	1.94	0.49	0.49	0.97	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	3.04	3.42	1.14	2.28	0.76	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	2.42	0.00	0.00	0.00	0.00	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	4.56	2.28	1.71	1.71	0.57	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	4.28	1.28	2.35	0.21	0.86	1.07	0.64	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	3.87	2.32	0.77	1.29	0.26	0.26	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	2.82	2.82	1.41	0.94	0.47	0.47	0.94	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	3.54	3.22	1.93	1.29	0.64	0.64	0.96	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	2.14	2.85	1.43	0.00	0.71	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	2.34	2.34	1.17	0.58	0.00	0.58	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	6.32	2.11	0.60	1.20	1.20	1.20	0.90	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	3.56	4.75	4.75	0.00	0.00	0.00	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	5.09	1.02	1.02	1.53	0.51	0.51	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	6.11	2.04	1.27	0.25	0.76	0.76	1.02	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	5.08	2.54	0.00	0.00	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	2.16	2.59	2.16	0.00	1.29	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	4.45	1.69	1.69	1.48	0.64	0.42	0.00	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	2.32	1.45	0.29	1.16	1.16	0.29	0.58	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	4.72	3.78	1.89	0.00	1.89	0.00	0.94	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	3.56	2.71	0.85	1.02	0.85	0.51	0.85	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	4.63	0.00	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	2.11	2.11	0.00	0.00	0.00	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	3.43	1.93	1.50	1.72	0.86	0.64	0.64	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	3.01	2.41	0.00	0.60	0.60	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	3.64	0.73	2.92	0.73	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	4.14	0.69	1.38	0.23	0.69	0.23	0.69	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	0.00	0.00	2.55	2.55	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	2.80	1.27	0.51	0.76	1.27	0.76	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	4.54	1.03	1.65	1.03	2.06	0.21	0.41	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	3.06	1.22	0.61	0.61	0.00	0.31	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	3.35	1.43	1.91	2.87	0.96	0.00	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	3.55	2.44	1.55	0.89	0.44	0.00	0.22	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	1.53	0.00	0.00	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	4.43	1.11	3.32	1.11	1.11	0.55	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	5.03	2.65	1.59	1.32	0.53	0.53	0.79	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	1.82	1.09	0.73	0.73	0.36	0.00	1.45	0.00
Astrocyte - cerebellum, donor1	11500-119F6	3.93	1.35	3.56	3.68	1.84	0.12	0.00	0.12
Astrocyte - cerebellum, donor2	11580-120F5	4.11	1.37	1.88	3.94	0.68	0.00	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	1.26	1.68	1.05	1.26	1.89	0.21	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	8.37	4.88	3.83	6.97	2.79	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	6.47	4.53	2.91	4.53	1.46	0.00	0.49	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	7.31	4.18	5.22	5.52	2.09	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	13.30	7.91	16.86	12.16	19.15	5.05	7.80	10.78
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	9.77	8.27	13.03	10.27	15.53	4.51	6.14	8.02
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	11.38	7.74	13.20	11.15	13.66	4.32	5.12	7.06
Basophils, donor1	12241-129G9	9.15	5.23	7.32	5.75	1.57	0.52	1.57	0.26
Basophils, donor2	12242-129H1	11.18	7.94	12.27	6.49	7.22	0.36	3.25	2.89
Basophils, donor3	12243-129H2	8.97	3.97	11.47	4.70	2.50	0.59	1.91	0.88
Bronchial Epithelial Cell, donor1	11511-119G8	12.94	4.96	2.16	0.22	0.22	0.43	0.22	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	10.52	7.77	1.37	0.46	0.91	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	7.53	3.14	2.51	1.88	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	7.69	4.57	0.62	1.66	1.04	0.21	0.00	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	9.44	4.15	2.53	1.38	0.46	0.46	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	14.58	4.86	0.90	1.26	0.54	0.72	0.54	0.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	2.37	1.34	0.21	0.41	0.82	2.06	1.65	2.27
Burkitt's lymphoma cell line:RAJI	10476-106I8	2.79	1.86	3.73	2.10	5.59	12.11	7.69	11.88
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	24.94	18.55	5.44	3.84	12.47	5.76	4.80	4.80
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	31.03	41.37	0.00	20.68	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	12.40	8.45	6.76	6.20	1.69	1.13	0.56	2.25
CD14+ Monocytes, donor2	11305-117B9	6.50	8.17	7.80	3.90	4.27	1.30	2.78	0.37
CD14+ Monocytes, donor3	11381-118B4	15.15	10.10	9.22	5.05	3.95	1.76	0.66	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	48.68	29.44	14.15	15.57	8.49	4.81	12.45	1.13
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	60.27	39.04	13.65	11.75	6.82	9.48	10.99	3.41
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	56.21	30.90	23.67	13.15	9.20	4.27	13.81	2.30
CD14+ monocytes - mock treated, donor1	11863-125A9	12.14	7.52	19.66	11.13	4.63	6.22	3.76	3.04
CD14+ monocytes - mock treated, donor2	11873-125C1	9.66	4.83	21.73	14.79	3.92	4.83	1.21	1.21
CD14+ monocytes - mock treated, donor3	11883-125D2	14.69	9.24	27.01	14.21	3.55	7.82	3.32	3.55
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	9.37	6.86	11.38	6.86	3.68	6.03	1.84	1.51
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	16.84	7.18	17.94	9.94	7.45	8.00	1.93	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	17.60	8.43	18.59	12.15	5.21	9.42	1.74	1.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	18.80	7.44	11.75	10.18	8.03	5.87	1.17	1.17
CD14+ monocytes - treated with BCG, donor2	11870-125B7	19.41	7.30	13.89	9.61	7.30	5.70	0.71	1.42
CD14+ monocytes - treated with BCG, donor3	11880-125C8	36.78	9.14	15.23	9.14	5.66	14.15	2.83	4.13
CD14+ monocytes - treated with Candida, donor1	11868-125B5	9.37	5.15	9.37	3.28	3.04	4.92	0.94	2.11
CD14+ monocytes - treated with Candida, donor2	11878-125C6	19.54	8.98	17.95	8.45	3.70	10.56	1.06	3.70
CD14+ monocytes - treated with Candida, donor3	11888-125D7	13.31	4.44	12.20	4.44	1.11	5.55	0.00	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	12.05	5.21	12.35	7.29	4.91	5.35	1.93	0.89
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	10.78	5.39	17.36	11.37	6.19	5.59	0.60	2.39
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	17.70	8.12	13.12	8.33	7.29	10.20	2.50	2.91
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	6.41	5.03	10.30	4.35	2.06	2.29	0.69	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	14.70	4.30	14.48	7.92	7.24	6.56	1.58	2.26
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	8.29	7.42	9.60	2.62	2.18	5.24	0.44	2.18
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	21.79	11.03	37.12	17.75	11.84	5.38	1.61	2.42
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	20.76	6.63	29.13	17.45	10.99	6.46	1.92	2.44
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	34.93	10.94	41.24	24.41	15.99	12.20	1.68	3.79
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	3.12	1.47	3.86	1.47	2.02	1.29	0.37	0.73
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	6.69	2.11	4.58	5.64	3.87	2.47	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	6.14	4.39	7.02	2.19	3.95	3.07	0.44	2.19
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	28.42	10.64	14.47	9.07	8.37	8.02	1.74	1.22
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	33.45	5.95	17.84	10.04	5.95	8.18	3.35	3.72
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	39.01	8.41	19.40	12.07	8.62	18.11	1.72	4.31
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	9.42	6.14	5.32	6.55	0.82	2.87	0.00	1.64
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	11.59	3.71	6.03	6.49	3.71	3.01	0.70	1.85
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	8.82	3.71	5.57	2.78	3.02	5.80	0.23	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	12.86	10.24	3.05	3.27	1.31	0.87	0.87	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	11.55	9.47	3.23	2.08	1.62	1.39	1.62	1.15
CD14+CD16+ Monocytes, donor3	11912-125G4	13.86	7.36	3.03	4.12	1.30	0.43	0.65	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	22.11	15.73	6.70	5.61	1.71	1.56	2.96	1.25
CD14+CD16- Monocytes, donor2	11799-124C8	19.39	10.83	5.06	2.79	2.10	1.22	3.32	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	36.12	21.41	10.93	8.70	5.13	0.67	3.34	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	13.27	11.23	3.32	1.79	1.02	1.53	1.28	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	14.71	6.59	1.76	1.32	0.88	0.88	1.10	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	11.79	9.26	1.89	3.79	1.05	0.63	0.21	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	10.16	6.10	8.13	6.10	20.32	0.00	6.10	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	13.56	6.10	8.81	4.07	21.70	1.36	8.81	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	6.21	5.18	15.53	4.14	18.64	1.04	6.21	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	19.19	12.79	5.33	7.46	33.58	9.06	7.46	9.59
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	16.08	15.01	9.11	3.22	26.27	8.04	8.04	5.90
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	14.74	4.21	11.93	3.51	23.16	1.40	5.62	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	7.84	5.49	8.63	7.06	21.96	0.78	3.92	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	10.55	15.82	6.59	5.27	22.41	0.00	2.64	1.32
CD19+ B Cells, donor1	11544-120B5	40.27	23.01	26.30	9.86	38.63	3.29	14.79	9.04
CD19+ B Cells, donor2	11624-122B4	13.06	7.98	14.51	6.53	31.19	0.73	4.35	3.63
CD19+ B Cells, donor3	11705-123B4	23.22	18.17	15.65	7.57	28.78	5.55	13.63	6.56
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	11.72	7.68	105.86	73.54	36.77	3.23	1.21	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	11.59	3.60	72.71	54.33	33.16	0.80	0.00	0.80
CD34+ Progenitors, donor1	11545-120B6	29.12	21.09	23.09	9.04	26.11	14.06	9.04	1.00
CD34+ Progenitors, donor2	11625-122B5	8.43	6.18	19.10	5.06	11.80	7.30	0.56	3.37
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	31.19	16.53	4.51	4.51	10.52	4.88	4.51	3.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	31.12	16.46	7.67	4.74	11.05	5.41	9.02	4.06
CD4+ T Cells, donor1	11225-116C1	44.63	31.42	4.64	3.93	26.78	5.71	7.86	6.43
CD4+ T Cells, donor2	11306-117C1	23.88	23.88	4.90	4.29	18.98	3.06	5.51	4.29
CD4+ T Cells, donor3	11382-118B5	30.19	25.01	4.57	3.35	19.82	2.74	4.88	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	14.55	12.00	2.30	6.13	7.66	3.06	8.42	2.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	17.29	12.13	3.14	2.25	7.19	2.92	11.01	2.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	19.55	14.09	2.30	3.16	8.34	4.31	7.47	1.44
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	23.70	19.44	1.42	1.90	5.69	3.32	10.43	3.32
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	38.63	21.77	2.11	0.00	7.73	5.62	11.94	7.02
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	13.18	39.55	6.59	0.00	9.89	3.30	3.30	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	9.97	7.95	2.75	5.06	5.35	3.47	6.50	2.75
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	11.52	10.00	3.05	6.78	9.32	2.37	5.08	2.37
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	8.87	11.12	4.19	5.48	7.09	2.90	6.61	1.45
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	23.76	17.48	2.24	1.79	5.83	4.03	8.52	1.79
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	24.11	15.02	2.45	1.75	4.19	6.99	12.58	2.45
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	41.36	20.24	2.64	3.52	5.28	8.80	16.28	6.60
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	6.75	10.54	6.75	5.06	11.81	0.42	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	8.73	10.18	4.16	3.95	8.93	1.45	4.99	1.04
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	7.02	7.68	2.00	3.34	8.69	0.67	2.34	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	33.72	17.40	2.72	2.72	16.32	1.90	7.61	1.63
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	49.84	36.44	2.14	3.75	13.40	5.90	9.11	2.68
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	28.69	19.73	3.59	0.00	14.35	0.00	3.59	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	9.83	12.42	7.60	6.68	13.35	0.93	4.08	1.11
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	11.48	13.00	2.60	5.20	11.91	1.08	4.55	1.73
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	10.51	11.56	4.62	5.04	13.24	1.26	4.20	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	21.74	12.13	1.52	4.55	10.11	1.52	5.56	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	27.73	21.23	1.73	3.47	5.20	2.60	7.37	2.17
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	29.64	19.18	3.92	6.10	12.20	4.79	10.46	1.74
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	22.27	12.87	3.46	5.44	20.78	0.00	4.95	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	20.31	6.46	4.62	3.69	20.31	0.00	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	18.15	6.98	1.40	2.79	11.17	0.00	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	30.19	27.42	5.26	6.92	10.25	3.88	4.71	2.49
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	36.81	22.09	5.64	7.36	13.74	4.91	3.68	1.96
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	15.40	12.32	6.16	4.62	15.40	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	16.47	10.74	4.30	7.16	13.61	0.72	4.30	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	20.77	12.46	5.54	5.54	12.46	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	22.26	13.42	5.24	1.64	14.08	4.91	10.80	5.57
CD8+ T Cells, donor2	11307-117C2	14.27	15.77	7.13	6.01	15.02	3.00	2.25	1.50
CD8+ T Cells, donor3	11383-118B6	18.68	16.66	6.56	2.52	14.39	3.03	6.31	2.78
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	1.15	0.69	2.52	1.84	1.61	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	1.92	0.72	2.40	0.96	0.72	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	1.37	0.82	1.09	1.64	0.82	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	2.10	0.60	1.50	1.50	0.90	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	4.08	0.72	2.16	0.96	1.44	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	2.50	0.68	2.27	2.27	1.14	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	1.74	1.96	3.04	1.30	1.52	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	2.11	0.79	2.63	2.37	1.84	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	1.64	0.94	3.05	1.17	1.88	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	1.51	0.30	3.62	1.81	1.51	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	3.49	0.58	1.45	1.16	3.20	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	2.66	1.07	4.00	1.33	1.07	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	2.63	1.31	3.94	3.06	3.94	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	1.37	3.19	3.64	1.82	5.01	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	1.49	1.49	6.71	2.98	0.75	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	2.16	0.72	2.16	3.24	1.80	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	1.73	1.15	2.30	2.30	1.44	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	1.41	0.47	1.41	1.18	1.89	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	4.44	0.00	4.12	1.58	0.32	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	3.69	0.62	3.08	0.92	0.92	0.00	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	1.92	1.28	3.21	1.28	2.56	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	3.82	2.29	3.06	1.53	1.91	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	1.58	1.58	3.94	1.97	2.36	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	2.27	0.00	3.03	0.76	2.27	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	0.80	0.80	6.42	1.61	3.21	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	4.20	2.80	1.40	2.10	4.90	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	3.01	5.01	5.01	3.01	3.01	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	36.55	25.59	7.31	5.48	3.66	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	9.88	5.93	2.47	0.49	1.48	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	6.84	3.16	2.42	0.95	0.95	0.00	0.11	0.00
Chondrocyte - de diff, donor1	11261-116G1	5.20	1.39	1.39	2.43	1.39	0.00	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	7.46	2.49	1.78	0.36	1.07	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	4.44	2.50	2.28	1.02	1.14	0.11	0.00	0.00
Chondrocyte - re diff, donor2	11339-117F7	20.59	8.06	9.85	6.27	0.90	0.90	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	9.71	4.45	2.83	2.02	1.21	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	5.28	2.30	7.92	4.71	2.64	0.00	0.11	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	6.41	2.35	5.13	2.78	0.86	0.00	0.00	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	7.17	2.65	6.55	3.81	2.12	0.00	0.09	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	25.31	20.17	23.57	13.57	8.07	2.38	3.03	1.38
Corneal Epithelial Cells, donor1	11526-119I5	10.54	3.07	2.20	0.88	0.44	0.88	0.44	0.66
Corneal Epithelial Cells, donor2	11606-120I4	10.24	11.38	3.41	2.28	1.14	1.14	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	7.16	3.83	2.05	1.28	1.53	0.77	0.00	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	32.85	23.44	10.07	6.44	14.03	13.54	7.92	3.30
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	31.54	21.13	9.15	7.57	12.62	13.25	8.83	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	27.61	3.45	13.80	10.35	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	18.14	11.88	7.02	6.37	7.13	5.62	4.86	1.40
Dendritic Cells - plasmacytoid, donor1	11228-116C4	29.04	28.70	3.76	2.05	4.78	1.37	6.49	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	26.77	27.42	4.57	3.26	6.53	3.92	8.49	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	30.97	13.07	2.42	1.94	7.26	4.36	4.36	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	11.67	5.50	3.50	2.17	2.00	1.83	1.33	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	7.63	1.17	2.93	0.59	0.00	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	10.75	5.94	5.66	1.41	1.98	1.70	1.13	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	7.47	5.50	3.54	2.36	2.75	0.00	1.18	0.39
Endothelial Cells - Artery, donor1	11264-116G4	5.53	4.36	2.91	2.91	0.00	2.04	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	11.76	7.76	4.24	2.82	1.41	1.65	3.29	0.24
Endothelial Cells - Artery, donor3	11413-118E9	9.12	5.26	3.33	2.45	2.45	2.45	1.05	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	19.95	6.43	8.87	3.77	3.55	2.66	3.55	0.89
Endothelial Cells - Lymphatic, donor2	11317-117D3	21.30	9.43	19.17	9.43	8.22	7.00	4.87	2.13
Endothelial Cells - Lymphatic, donor3	11393-118C7	25.94	10.99	18.04	8.74	6.77	4.51	3.66	1.13
Endothelial Cells - Microvascular, donor1	11265-116G5	4.75	1.49	5.35	2.38	0.59	0.30	0.89	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	7.81	3.12	3.64	0.00	1.56	1.56	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	6.24	3.54	4.96	2.55	1.28	0.00	0.71	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	13.20	6.40	7.60	4.00	4.80	3.20	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	6.29	2.62	5.24	1.05	3.67	0.52	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	26.09	15.03	19.76	9.07	6.83	5.72	6.59	1.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	21.29	12.38	13.69	9.34	5.00	2.17	2.82	0.87
Endothelial Cells - Umbilical vein, donor3	11400-118D5	24.55	13.92	13.56	9.65	4.40	3.66	4.52	1.34
Endothelial Cells - Vein, donor1	11267-116G7	5.69	5.69	1.14	3.41	1.14	0.00	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	7.68	5.59	3.49	1.40	2.79	0.70	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	4.87	4.87	3.30	1.26	1.41	0.94	0.94	1.10
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00	0.00	0.00	15.25	0.00
Eosinophils, donor2	12245-129H4	9.90	3.30	70.96	18.15	4.95	0.00	1.65	0.00
Eosinophils, donor3	12246-129H5	7.13	3.57	74.90	7.13	21.40	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	12.22	3.66	2.20	0.98	0.73	0.49	0.49	0.98
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	2.08	4.16	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	9.03	5.34	1.23	1.23	0.82	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	4.27	2.52	0.88	0.77	0.66	0.22	0.00	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	2.60	2.06	1.41	0.98	0.54	0.11	0.00	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	5.94	4.49	1.82	1.58	0.73	0.00	0.24	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	28.11	14.88	3.68	3.14	3.00	3.00	1.09	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	6.96	3.48	2.21	1.90	1.58	0.11	0.21	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	16.60	11.07	7.90	4.22	3.69	0.26	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	8.30	3.99	1.00	1.66	0.33	0.00	1.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	8.17	3.18	1.36	1.81	0.91	0.45	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	9.85	3.79	2.27	3.03	3.03	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	4.10	1.58	1.58	1.42	0.32	0.00	0.16	0.00
Fibroblast - Cardiac, donor4	11452-119A3	26.67	10.00	14.25	8.49	5.76	0.00	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	11.55	4.57	5.58	2.16	0.63	0.13	0.13	0.00
Fibroblast - Cardiac, donor6	11460-119B2	15.92	5.46	4.70	4.40	1.52	0.15	0.45	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	20.90	7.77	14.60	8.17	3.62	0.94	0.80	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	5.61	3.45	5.18	4.75	2.59	0.43	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	5.86	5.86	4.39	2.93	4.39	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	10.15	2.77	2.77	2.31	0.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	7.12	4.75	1.70	1.70	1.02	0.00	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	11.97	5.87	1.64	0.70	1.64	0.23	0.23	0.23
Fibroblast - Dermal, donor2	11346-117G5	13.21	3.30	0.00	1.89	2.36	0.47	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	8.82	3.51	0.97	1.57	0.85	0.00	0.12	0.00
Fibroblast - Dermal, donor4	11450-119A1	8.37	2.49	3.28	3.84	0.79	0.00	0.00	0.00
Fibroblast - Dermal, donor5	11454-119A5	7.50	3.31	4.54	2.62	1.05	0.00	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	12.51	3.74	3.09	4.87	1.46	0.00	0.00	0.16
Fibroblast - Gingival, donor1	11237-116D4	15.62	5.83	3.96	3.33	2.50	0.21	0.62	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	8.91	3.93	3.41	1.57	0.79	0.26	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	6.72	2.11	3.29	2.37	2.11	0.00	0.00	0.00
Fibroblast - Gingival, donor3	11394-118C8	10.44	7.06	3.29	5.22	2.13	0.10	0.19	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	10.39	4.16	0.00	6.23	1.04	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	10.04	3.88	1.06	2.47	2.47	0.00	0.00	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	10.29	2.49	4.68	3.27	1.87	0.00	0.00	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	10.41	4.87	2.03	3.38	2.57	0.14	0.00	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	26.47	10.23	4.23	4.59	2.47	1.41	1.06	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	12.14	4.39	1.75	3.66	2.92	0.00	0.15	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	8.32	3.27	3.55	3.55	2.45	0.00	0.00	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	8.67	3.95	2.41	2.19	1.76	0.22	0.11	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	7.63	4.70	2.64	3.96	1.32	0.00	0.15	0.15
Fibroblast - Lung, donor1	11270-116H1	1.36	0.00	0.00	0.00	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	4.48	2.98	1.49	1.49	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	3.80	1.48	1.06	2.32	0.42	0.00	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	39.15	10.00	5.83	5.00	5.83	1.67	0.00	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	5.59	8.39	4.20	2.80	2.80	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	5.32	4.20	0.56	0.56	0.28	0.28	0.28	0.28
Fibroblast - Mammary, donor1	11540-120B1	26.39	7.31	6.90	5.28	4.87	1.22	1.62	0.41
Fibroblast - Mammary, donor2	11620-122A9	27.96	7.99	3.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	7.56	3.10	4.27	3.30	1.16	0.00	0.39	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	13.65	4.70	5.31	6.07	2.28	0.00	0.30	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	40.08	12.24	6.12	9.79	6.43	0.31	2.14	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	10.69	3.43	0.76	2.67	0.76	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	7.29	2.43	1.89	2.16	0.27	0.27	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	13.11	5.45	3.48	3.13	2.09	0.00	0.00	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	3.76	1.77	1.44	1.44	0.33	0.11	0.22	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	20.93	4.27	10.97	6.71	4.47	0.81	0.20	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	6.68	3.34	2.67	2.00	0.00	0.00	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	5.93	1.58	0.40	0.79	0.79	0.00	0.79	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	19.45	6.75	4.96	2.98	1.79	0.00	0.40	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	6.04	1.24	1.95	1.24	0.18	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	12.02	3.55	2.37	2.96	1.18	0.00	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	11.43	2.41	2.11	3.01	0.60	0.00	0.30	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	11.44	3.13	1.84	1.84	0.86	0.00	0.11	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	19.23	7.85	3.80	3.04	1.52	0.00	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	9.35	4.59	2.30	2.13	0.49	0.00	0.16	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	18.45	8.22	4.61	3.41	1.80	0.20	0.20	0.20
Fibroblast - skin normal, donor2	11561-120D4	11.15	3.11	2.81	2.11	0.70	0.20	0.20	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	25.99	9.97	5.44	3.93	1.21	0.30	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	10.02	4.31	1.91	2.07	1.08	0.08	0.08	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	10.43	2.74	3.25	2.39	1.37	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	15.76	4.93	3.61	1.64	0.99	0.33	0.33	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	9.05	2.34	1.70	2.56	0.43	0.21	0.00	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	10.96	4.72	2.87	1.35	0.51	0.00	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	4.70	1.25	0.78	0.78	0.63	0.00	0.16	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	22.16	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	40.96	30.50	6.10	5.23	2.61	1.74	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	11.61	3.64	4.16	0.52	0.69	2.25	2.77	2.08
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	20.56	7.55	2.34	1.30	1.04	4.68	2.34	1.30
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	26.83	7.41	3.07	1.53	1.79	4.60	3.58	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	20.67	14.55	3.83	1.53	1.53	0.00	3.83	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	20.42	17.87	5.74	3.83	1.91	0.64	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	35.66	34.80	16.26	6.85	1.43	2.85	2.57	2.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	20.68	20.96	23.72	8.55	0.55	0.28	0.55	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	11.42	13.93	19.41	10.50	2.28	0.68	0.23	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	32.89	23.78	12.48	5.15	0.99	2.58	1.59	1.78
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	19.30	14.01	19.83	5.82	0.00	0.26	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	13.70	13.70	28.70	15.00	2.28	0.00	0.33	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	31.84	34.49	13.71	6.63	0.88	6.19	2.65	6.19
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	26.29	18.94	10.03	2.54	2.69	4.38	1.98	6.36
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	19.58	14.90	12.07	5.42	1.97	2.34	1.48	4.68
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	19.88	13.97	6.98	1.88	3.76	1.07	1.61	3.76
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	15.49	8.18	6.69	4.09	1.49	1.12	0.62	2.60
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	22.15	10.80	7.75	4.15	2.35	2.91	0.83	4.57
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	18.91	9.35	4.47	4.27	2.44	2.64	0.81	4.47
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	13.01	5.02	4.79	2.74	0.91	3.19	1.37	2.51
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	15.20	6.23	6.23	2.87	2.49	3.24	0.75	3.49
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	21.64	12.24	7.21	3.28	2.40	2.84	1.53	4.37
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	7.09	5.02	5.32	3.55	2.07	1.18	0.89	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	12.72	6.99	7.63	4.61	1.91	2.23	0.95	2.70
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	15.42	7.82	6.93	2.90	2.23	4.47	0.45	4.47
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	6.86	4.64	4.64	4.64	1.21	0.40	1.01	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	9.67	3.22	8.14	2.88	0.51	1.36	0.51	1.70
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	15.78	8.69	8.42	4.61	2.31	3.72	1.68	3.46
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	6.87	4.68	8.12	5.51	3.12	0.94	1.04	1.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	12.64	5.98	5.98	4.78	1.54	0.51	0.51	1.02
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	6.75	3.65	9.52	4.54	1.44	0.22	0.33	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	11.31	7.24	7.40	3.91	3.00	2.00	1.41	1.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	13.88	7.55	5.51	4.90	1.02	1.84	1.02	1.43
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	5.16	2.06	3.30	2.48	0.83	0.00	0.41	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	5.76	3.46	8.88	3.80	1.73	0.23	0.12	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	6.84	3.67	5.84	3.67	1.33	0.50	0.83	1.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	4.63	3.97	3.31	3.31	0.22	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	9.10	3.69	5.29	3.20	0.98	0.12	0.25	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	6.16	4.70	8.27	4.70	1.13	0.32	1.30	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	5.45	3.85	6.74	5.45	0.64	0.00	1.60	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	5.21	3.41	5.87	2.84	0.95	0.19	0.57	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	5.06	3.16	3.16	2.21	1.11	0.32	0.63	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	4.56	2.74	5.47	1.22	1.52	1.22	2.13	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	4.39	3.35	4.91	2.82	0.94	0.42	0.63	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	6.37	3.07	5.93	3.73	1.32	0.44	1.10	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	7.29	2.52	5.05	2.52	0.84	0.00	0.56	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	4.91	2.31	5.56	2.69	1.39	0.19	0.37	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	5.88	2.94	2.94	1.60	1.34	0.53	1.07	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	5.97	2.14	3.37	3.21	1.22	0.15	2.30	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	4.66	1.68	3.37	1.55	0.65	0.26	1.17	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	6.23	3.52	4.34	2.71	1.63	0.00	1.08	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	7.01	3.13	3.87	3.13	1.66	0.37	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	7.24	3.29	3.51	2.19	2.19	0.22	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	19.83	5.95	6.94	11.90	2.98	0.00	2.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	9.23	6.20	4.62	2.90	3.43	0.53	1.32	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	6.86	2.62	2.62	2.82	2.22	0.40	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	27.96	10.42	24.40	12.71	7.37	0.25	2.29	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	51.56	31.85	9.95	3.18	3.18	7.56	4.18	8.36
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	36.05	26.35	9.71	4.78	4.16	2.47	2.62	4.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	49.51	33.96	10.84	2.86	1.64	4.09	2.05	6.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	13.14	16.27	2.50	1.25	0.94	1.25	0.94	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	14.41	10.45	1.70	0.57	0.57	0.28	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	32.75	31.82	6.92	2.77	0.92	1.84	1.84	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	49.50	17.32	7.42	7.42	0.00	2.47	2.47	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	25.92	19.34	12.76	3.09	5.03	3.48	1.16	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	20.86	12.84	16.04	0.00	3.21	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	38.25	12.17	13.91	3.48	3.48	3.48	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	24.09	17.90	8.79	2.60	4.23	1.30	0.65	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	22.65	25.12	11.94	4.53	3.71	0.82	0.82	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	33.32	23.33	23.33	3.33	6.66	3.33	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	14.82	12.58	9.79	3.64	1.68	0.00	0.56	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	17.98	10.79	7.84	2.29	1.96	2.29	1.31	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	23.49	10.07	13.42	5.87	3.36	2.52	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	14.95	7.63	14.95	2.86	3.50	1.27	0.64	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	14.27	10.87	7.47	2.38	2.04	0.00	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	22.97	16.71	12.53	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	14.89	10.31	12.60	2.86	0.00	0.00	1.15	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	14.50	4.74	8.88	1.48	1.18	0.00	0.00	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	13.55	1.69	15.25	1.69	0.00	1.69	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	8.28	8.70	12.43	7.46	2.07	1.66	0.83	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	11.97	11.74	9.67	5.06	2.99	0.23	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	0.00	0.00	15.81	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	9.61	5.77	9.23	3.46	3.08	0.77	0.38	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	8.48	5.54	8.80	3.91	1.63	0.33	0.65	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	8.69	6.02	9.36	1.34	0.00	0.67	0.67	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	15.03	10.40	11.17	3.47	2.70	1.54	1.16	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	16.09	8.56	18.49	5.48	2.05	0.68	0.34	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	14.91	4.97	14.91	4.97	0.00	0.00	2.48	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	8.49	7.08	12.27	3.30	1.42	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	9.66	6.64	8.45	3.02	3.02	0.60	2.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	9.16	5.60	10.17	4.58	0.51	0.00	0.00	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	13.96	8.38	10.37	5.18	0.80	0.80	1.60	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	14.80	6.91	11.35	2.96	0.99	0.49	0.00	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	22.43	14.17	14.17	4.72	1.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	16.92	7.00	10.50	3.50	2.33	1.17	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	15.36	7.02	10.09	4.83	3.07	0.00	1.32	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	11.87	5.09	14.41	6.78	0.00	0.00	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	7.76	1.19	14.33	3.58	0.60	0.00	2.39	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	5.34	6.79	8.25	2.91	0.97	0.49	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	22.83	5.71	6.85	3.42	3.42	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	13.31	7.07	4.16	3.33	3.33	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	5.62	2.25	2.25	2.25	2.25	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	10.47	3.17	2.54	1.59	0.95	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	4.18	0.42	0.42	0.84	1.25	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	8.12	4.41	3.25	0.58	0.70	2.90	0.93	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	10.13	2.53	2.53	1.18	2.19	1.86	1.18	1.01
Hep-2 cells mock treated, biol_rep3	11900-125F1	7.05	3.41	4.55	0.00	0.68	1.37	0.46	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	6.56	2.84	1.09	0.44	0.66	1.97	0.87	0.66
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	9.03	4.30	2.79	0.86	1.50	1.72	1.29	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	7.75	2.15	1.94	1.51	1.08	0.65	0.22	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	8.09	5.48	1.99	0.75	1.99	2.24	1.25	1.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	10.64	4.80	2.40	1.20	0.17	1.89	0.51	1.20
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	7.37	4.16	2.24	1.92	1.28	2.88	0.64	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	14.55	5.60	17.91	6.16	6.72	0.56	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	7.36	2.60	3.46	3.03	0.43	0.87	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	10.58	5.29	0.00	0.00	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	11.29	5.64	4.23	3.17	1.06	0.71	2.47	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	9.44	0.73	2.91	1.45	0.73	0.00	0.73	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	6.64	1.57	2.80	1.75	1.22	0.00	0.17	0.00
Hepatocyte, donor1	11523-119I2	23.00	30.27	19.37	8.47	6.05	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	11.85	14.01	5.39	3.23	2.15	1.08	2.15	0.00
Hepatocyte, donor3	11684-122I1	14.72	15.34	17.18	7.36	1.84	0.00	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	10.44	6.53	1.31	3.26	10.44	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	12.06	11.01	19.23	3.85	5.07	0.52	2.10	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	4.80	3.70	2.06	0.96	0.82	0.41	0.27	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	3.18	9.55	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	0.00	13.35	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	27.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	2.77	4.15	0.00	1.38	0.00	0.00	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	0.00	5.01	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	11.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	5.13	5.13	2.56	5.13	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	4.57	4.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	3.25	1.62	1.62	3.25	0.00	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	5.00	5.00	8.34	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	3.63	3.63	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	5.29	2.65	10.59	1.32	0.00	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	4.43	0.00	5.54	3.33	1.11	0.00	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00	5.24	5.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	2.52	0.00	6.93	0.63	0.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	4.64	0.00	4.64	9.28	1.55	0.00	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	29.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	3.88	3.88	8.40	3.88	0.65	0.00	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	3.22	3.22	16.10	1.61	3.22	1.61	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	4.07	5.70	8.15	6.52	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	4.20	0.84	3.36	1.26	0.84	0.84	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	14.37	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	3.21	1.61	8.04	4.02	0.80	0.00	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	1.85	0.92	5.54	1.85	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	0.94	0.00	4.25	2.36	0.00	0.00	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	3.63	0.91	1.81	1.81	0.91	0.00	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	8.61	2.15	5.38	3.23	0.00	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	3.81	2.54	7.62	1.27	1.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	3.19	0.00	6.38	0.64	0.00	0.00	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	3.65	1.82	1.82	1.82	0.00	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	15.80	15.80	0.00	0.00	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	4.28	1.43	5.00	2.86	0.71	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	0.00	3.32	3.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	4.01	2.16	2.78	2.16	0.31	0.31	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	7.02	1.76	0.00	0.00	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	3.14	3.14	12.57	0.00	6.29	0.00	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	2.78	1.39	8.34	3.48	1.39	0.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	8.85	2.21	8.85	0.00	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	6.48	9.73	3.24	0.00	0.00	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	1.74	1.74	8.72	1.74	0.87	0.87	0.87	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	4.50	4.50	6.75	4.50	2.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	6.97	3.48	6.97	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	1.07	2.13	8.53	3.20	3.20	0.00	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	2.77	1.39	2.77	8.31	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	5.70	2.85	2.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	3.68	0.92	6.44	2.76	0.92	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	3.03	3.03	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	0.00	12.42	12.42	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	5.29	1.06	4.23	4.23	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	12.89	6.77	1.96	1.14	0.73	1.06	0.98	0.98
Keratinocyte - epidermal, donor2	11349-117G8	6.44	1.76	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	10.13	5.21	1.42	0.85	0.85	0.85	1.23	0.66
Keratinocyte - oral, donor1	11251-116E9	17.37	6.24	6.47	1.25	1.36	2.16	2.50	1.25
Keratocytes, donor1	11527-119I6	4.81	4.13	3.09	3.09	0.34	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	5.86	3.52	2.34	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	3.36	0.99	0.99	0.40	0.59	0.00	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	46.16	24.18	26.37	6.59	2.20	4.40	0.00	4.40
Lens Epithelial Cells, donor1	11529-119I8	7.55	2.16	2.16	1.08	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	3.92	1.50	6.46	2.88	1.50	0.00	0.12	0.00
Lens Epithelial Cells, donor3	11690-122I7	9.79	3.63	7.67	4.14	2.02	0.00	0.10	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	16.25	6.28	4.98	3.08	2.96	0.24	0.36	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	6.70	4.19	2.23	2.51	1.67	0.56	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	13.07	6.14	4.56	3.78	3.78	0.31	0.16	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	12.37	3.23	3.23	1.61	2.15	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	12.29	5.99	2.21	1.26	1.89	0.00	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	6.25	3.45	2.80	1.83	1.51	0.11	0.22	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	13.95	4.10	2.87	3.69	2.46	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	5.56	3.29	1.52	1.26	1.01	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	8.73	4.93	3.38	3.24	2.25	0.56	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	11.07	7.12	3.96	1.98	2.37	0.79	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	7.95	4.46	3.88	2.33	2.13	1.16	0.39	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	3.15	3.33	1.11	0.74	0.56	0.00	0.19	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	12.19	7.32	2.44	1.05	1.39	0.35	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	8.59	5.01	2.62	1.67	1.67	0.24	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	7.14	3.71	3.43	2.06	1.92	0.00	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	15.40	5.85	2.77	3.39	3.08	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	3.74	3.43	1.56	0.94	0.62	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	7.69	5.86	4.76	1.46	1.83	0.18	0.37	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	14.48	8.23	3.29	2.30	2.63	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	4.69	3.81	2.05	0.59	2.34	0.29	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	4.23	5.23	3.49	1.49	1.24	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	15.52	4.85	1.45	2.42	4.36	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	9.43	6.46	1.89	2.15	3.77	0.00	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	5.45	4.39	5.30	2.88	2.27	0.45	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	8.81	5.18	3.63	0.52	3.63	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	11.31	5.23	3.98	2.09	1.68	0.42	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	6.32	3.91	2.56	1.95	1.50	0.15	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	11.69	4.13	1.38	2.06	0.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	8.65	4.14	4.14	1.32	2.45	0.19	0.38	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	5.73	3.39	3.29	1.27	2.12	0.00	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	14.05	6.78	3.88	2.42	5.33	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	3.97	5.95	1.98	0.99	0.99	0.33	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	5.95	3.10	3.22	1.12	1.98	0.12	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	22.95	7.40	7.03	3.70	4.07	0.37	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	6.67	4.45	3.46	1.48	0.99	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	5.22	2.47	1.51	1.24	2.20	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	16.40	7.40	3.54	1.29	1.93	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	10.96	6.70	3.35	0.91	1.83	0.61	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	8.96	5.88	3.92	2.10	3.36	0.00	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	9.96	4.98	2.49	3.56	2.13	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	5.33	4.85	0.97	0.48	2.42	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	6.54	1.87	2.33	1.56	0.78	0.00	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	14.68	3.58	1.79	0.72	1.79	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	9.15	4.90	3.27	0.98	1.63	0.98	0.98	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	2.59	0.94	2.59	0.71	0.24	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	16.21	8.04	4.21	4.46	3.59	0.74	0.62	0.74
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	5.63	2.82	1.79	1.79	1.54	0.51	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	10.74	2.39	2.39	2.39	2.39	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	13.60	6.80	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	8.44	3.07	3.84	0.77	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	2.97	3.71	2.97	0.74	1.48	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	8.46	7.62	2.54	1.27	1.27	0.00	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	7.03	2.11	2.11	1.41	0.70	2.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	5.60	1.87	1.87	0.93	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	9.79	3.61	2.58	0.52	1.03	0.52	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	3.57	2.38	2.38	0.00	1.19	2.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	6.79	4.30	2.49	0.45	1.13	0.68	0.00	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	8.43	3.49	1.74	1.45	1.16	0.87	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	6.75	4.05	2.70	1.80	1.35	0.90	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	7.72	4.74	3.12	2.30	2.17	1.90	0.95	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	8.22	3.08	2.05	1.54	1.03	2.57	0.51	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	8.12	3.88	2.47	1.06	1.06	1.06	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	7.33	2.67	0.67	1.33	0.67	1.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	9.68	7.13	3.06	0.51	1.02	3.57	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	6.14	4.27	2.13	0.80	1.60	2.40	0.53	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	9.07	2.65	4.72	0.76	1.13	1.32	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	12.27	6.14	3.07	1.23	1.23	1.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	13.05	5.71	3.26	0.82	0.00	2.45	1.63	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	7.50	3.33	4.79	1.25	0.42	1.04	1.04	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	10.09	3.92	3.08	1.12	1.68	1.12	0.28	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	9.27	4.12	2.06	2.06	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	6.39	4.35	4.64	1.74	0.87	0.87	0.87	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	8.97	5.08	2.99	1.49	0.60	0.60	0.90	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	4.43	4.98	1.66	0.55	1.11	1.66	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	12.02	4.24	4.24	1.77	0.71	0.35	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	12.91	5.16	3.69	1.11	1.84	2.58	0.74	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	2.30	4.61	5.76	1.15	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	7.29	6.52	2.30	0.38	0.38	1.92	0.77	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	11.32	4.53	2.26	1.13	1.13	1.13	0.57	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	4.10	1.64	3.28	0.00	0.82	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	9.94	3.16	4.07	0.90	0.45	1.36	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	7.90	4.31	2.87	0.00	0.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	8.22	5.23	4.48	0.00	2.24	1.49	0.75	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	5.57	5.57	3.72	0.74	1.86	1.49	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	9.48	4.31	2.58	0.43	1.29	1.29	0.43	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	11.13	6.85	0.86	0.00	0.86	2.57	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	7.66	2.33	2.00	1.33	1.00	0.33	0.33	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	8.45	5.43	1.81	1.81	1.21	1.21	1.21	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	9.24	4.98	3.55	0.71	1.42	2.13	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	8.25	4.12	2.41	2.41	2.41	1.37	0.69	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	8.59	4.83	1.07	0.00	2.15	1.07	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	7.41	6.06	4.04	1.35	0.67	0.67	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	8.52	4.07	4.44	2.59	0.74	1.11	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	5.81	11.63	3.49	2.33	1.16	1.16	2.33	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	9.52	2.12	4.23	1.06	0.00	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	7.20	6.00	2.00	1.20	2.00	1.20	0.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	10.18	6.54	5.09	0.73	1.45	0.00	2.18	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	11.50	9.20	3.07	0.77	1.53	0.00	1.53	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	8.39	3.95	4.44	2.47	0.49	0.99	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	8.47	8.47	2.82	0.00	0.94	1.88	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	7.04	2.01	2.01	0.50	1.01	1.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	13.52	4.51	3.60	1.35	0.90	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	10.33	8.61	1.72	0.00	3.44	1.72	1.72	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	14.25	4.45	5.34	0.45	2.23	1.34	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	9.78	6.65	2.74	1.96	1.56	2.35	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	17.81	2.64	3.30	1.32	1.98	3.96	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	13.49	5.71	4.67	1.56	0.52	2.08	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	12.25	7.44	4.38	2.19	2.19	2.63	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	13.42	8.39	2.24	2.80	2.24	1.12	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	14.13	5.30	3.97	1.32	2.65	0.44	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	8.49	6.17	3.09	0.77	0.39	1.16	0.00	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	13.17	6.58	2.53	2.53	1.01	1.52	0.51	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	9.13	2.40	4.33	1.44	1.44	1.92	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	12.72	5.17	5.17	2.39	0.40	2.39	0.00	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	9.72	6.68	4.86	2.43	0.61	1.82	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	7.61	2.08	2.77	0.00	1.38	3.46	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	15.20	6.08	2.28	2.28	2.28	2.28	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	9.81	5.68	4.13	2.07	0.00	3.10	0.52	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	7.26	2.42	3.63	1.21	0.60	1.21	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	13.31	6.34	1.58	2.54	1.90	2.22	0.63	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	13.33	7.46	3.20	1.07	1.60	1.07	0.53	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	9.77	5.75	2.87	4.02	0.00	1.72	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	12.86	3.60	2.06	1.54	1.54	1.03	1.54	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	7.07	6.37	0.71	2.12	0.00	3.54	0.00	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	6.24	3.40	3.40	2.27	0.57	1.13	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	9.15	5.82	3.74	1.66	0.42	2.08	0.42	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	7.05	4.70	0.00	0.78	0.78	3.92	0.78	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	7.93	4.59	3.34	2.92	0.84	0.42	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	11.15	5.11	3.25	2.79	1.39	1.39	0.46	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	11.37	7.36	1.34	1.34	0.67	1.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	9.62	4.28	1.07	2.67	1.60	2.14	0.00	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	14.95	4.85	2.42	0.81	0.81	0.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	5.51	4.59	4.59	0.00	1.84	2.75	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	8.89	2.67	2.67	1.78	2.67	1.78	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	9.12	6.27	3.42	1.14	1.14	2.28	0.00	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	12.27	8.44	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	9.85	2.19	0.00	1.64	1.09	0.00	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	16.04	3.12	2.23	0.89	0.00	0.89	0.89	2.23
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	11.70	5.46	1.56	2.34	1.04	0.52	0.52	1.04
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	8.62	5.30	1.99	1.33	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	10.39	2.08	0.00	2.08	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	28.72	15.50	9.57	9.57	4.33	5.24	4.79	0.23
Macrophage - monocyte derived, donor2	11313-117C8	12.66	8.99	2.02	2.57	1.28	2.57	2.75	0.92
Macrophage - monocyte derived, donor3	11389-118C3	17.96	10.88	4.72	4.59	2.88	2.23	2.75	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	7.43	2.66	1.59	1.06	0.53	1.59	1.06	0.53
Mallassez-derived cells, donor2	11929-125I3	27.10	7.76	7.29	0.48	1.74	5.23	2.22	1.43
Mallassez-derived cells, donor3	11930-125I4	19.88	8.62	3.20	0.83	0.56	4.59	2.22	1.11
Mammary Epithelial Cell, donor1	11273-116H4	16.74	8.57	1.79	1.20	1.20	0.70	0.60	0.70
Mammary Epithelial Cell, donor2	11350-117G9	8.69	6.08	1.45	1.74	1.45	0.29	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	4.49	2.74	0.25	1.00	1.25	0.50	0.75	0.25
Mast cell - stimulated, donor1	11487-119E2	73.90	23.73	86.78	80.00	119.99	101.01	33.90	16.95
Mast cell, donor1	11563-120D6	18.60	9.41	17.74	10.38	7.35	6.81	7.68	1.41
Mast cell, donor2	11565-120D8	59.14	25.56	47.55	25.85	11.59	26.45	20.21	12.48
Mast cell, donor3	11566-120D9	55.38	29.72	48.85	26.11	9.91	33.32	36.47	19.14
Mast cell, donor4	11567-120E1	60.99	23.93	41.49	24.64	10.99	15.42	24.47	7.80
Mast cell, expanded and stimulated, donor5	11940-126A5	23.84	13.20	21.29	14.64	11.42	12.09	13.53	8.54
Mast cell, expanded and stimulated, donor8	11942-126A7	19.85	12.26	10.51	10.51	23.35	15.18	11.67	4.67
Mast cell, expanded, donor5	11939-126A4	20.08	11.70	13.77	10.67	5.39	3.10	5.74	0.57
Mast cell, expanded, donor8	11941-126A6	17.57	6.53	27.78	13.72	10.04	8.87	16.07	3.01
Melanocyte - dark, donor1	11502-119F8	8.66	4.28	6.37	4.68	0.90	0.00	0.00	0.20
Melanocyte - dark, donor2	11582-120F7	9.69	2.77	5.54	2.77	2.77	0.35	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	9.27	2.68	2.46	4.56	3.40	0.14	0.00	0.07
Melanocyte - light, donor1	11274-116H5	9.17	3.53	0.94	4.23	3.76	0.00	0.00	0.24
Melanocyte - light, donor2	11351-117H1	7.51	1.36	5.46	1.36	2.73	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	4.34	1.73	0.00	0.87	0.00	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	8.54	3.85	2.50	2.71	1.35	0.00	0.21	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	8.07	3.77	1.88	2.69	3.23	1.08	0.81	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	13.12	3.48	2.68	4.82	2.14	0.00	0.00	0.00
Meningeal Cells, donor1	11493-119E8	23.70	10.55	6.45	8.68	5.21	0.12	0.62	0.62
Meningeal Cells, donor2	11573-120E7	12.32	4.40	11.00	3.52	1.32	0.00	0.44	0.00
Meningeal Cells, donor3	11654-122E7	8.97	4.24	2.93	3.02	2.36	0.49	1.71	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	4.56	1.43	2.28	3.99	0.29	0.29	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	6.54	2.72	5.03	2.31	0.40	0.40	0.40	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	10.51	1.31	1.31	3.94	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	10.47	3.92	0.00	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	9.33	1.44	0.00	2.15	2.15	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	12.28	5.29	4.87	1.27	1.91	0.00	0.00	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	10.05	6.53	4.52	0.50	1.51	1.01	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	7.69	1.10	1.98	2.86	0.66	0.22	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	5.11	2.19	1.46	5.11	0.73	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	5.52	2.05	2.86	3.48	1.02	0.00	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	2.91	1.80	2.49	1.39	1.25	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	7.43	3.72	8.55	2.97	2.60	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	8.29	3.95	8.82	2.24	3.29	0.00	0.39	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	5.34	0.59	6.83	2.08	0.59	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	4.67	0.00	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	5.76	3.84	9.61	0.64	0.64	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	6.38	1.77	1.77	0.71	4.25	0.71	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	6.57	1.25	6.88	2.50	1.56	0.00	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	4.35	0.73	3.63	1.45	1.45	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	40.57	15.65	2.65	1.86	2.12	9.02	3.98	1.86
Mesothelial Cells, donor2	12156-128G5	24.52	11.51	2.50	0.50	0.50	1.00	0.00	1.50
Mesothelial Cells, donor3	11402-118D7	55.64	26.45	1.81	1.01	1.45	8.38	3.40	2.10
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	22.96	14.85	9.45	4.05	2.70	4.05	2.70	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	29.80	18.72	5.42	7.88	3.69	3.94	3.69	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	10.01	9.42	5.01	2.94	5.59	3.24	2.94	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	6.91	3.46	6.91	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	29.75	9.30	5.89	4.34	3.72	1.55	0.93	1.24
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	12.45	5.39	3.73	2.28	3.73	2.07	1.45	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4.63	6.95	6.95	4.63	4.63	2.32	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	22.27	9.01	5.26	5.26	3.75	3.25	3.00	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	13.96	12.10	6.52	4.19	2.79	3.26	3.72	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	17.48	9.35	3.05	4.06	3.25	0.61	1.83	1.22
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	12.67	6.34	3.96	4.36	4.36	2.38	1.58	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	0.00	17.10	0.00	0.00	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	15.93	11.50	2.65	2.65	1.77	4.42	0.00	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	6.46	3.80	3.80	2.66	3.42	1.90	1.90	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	13.16	10.53	3.95	6.58	5.26	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	19.95	7.85	4.03	2.97	3.40	3.40	2.33	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	5.52	3.68	1.84	3.68	3.68	0.92	2.76	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	13.41	6.26	3.58	1.49	3.87	2.98	1.49	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	6.71	5.03	5.03	3.35	3.35	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	15.05	6.02	2.51	2.51	1.51	3.51	2.76	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	7.61	5.47	2.14	2.14	4.04	1.43	1.19	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	4.42	5.53	2.21	2.76	5.53	4.42	1.66	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	9.44	4.14	2.30	2.76	4.84	2.07	1.15	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	8.20	6.52	4.00	2.52	4.21	1.68	1.05	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	8.56	4.48	2.85	2.85	5.71	2.65	2.04	0.82
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	13.09	3.43	2.57	1.93	5.36	3.86	2.79	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	7.56	4.00	3.78	1.56	4.22	1.78	2.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	10.32	0.00	0.00	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	8.32	3.29	1.97	1.53	7.45	1.97	1.10	1.53
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	6.08	3.55	3.55	3.55	4.06	1.01	1.01	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	8.28	3.31	6.63	3.31	3.31	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	12.23	3.26	3.53	4.08	11.69	4.62	0.27	1.90
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	11.18	6.47	2.06	2.06	7.65	2.35	0.88	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	4.36	3.27	5.45	1.09	13.08	2.18	1.09	2.18
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	5.77	2.88	3.84	2.40	9.61	1.44	1.44	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	11.61	6.00	2.40	2.80	14.01	4.00	1.20	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	21.94	4.11	15.08	5.48	2.74	2.74	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	6.01	4.00	6.01	1.00	8.01	1.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	0.00	4.08	4.08	10.19	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	11.82	3.50	3.07	2.19	10.95	1.31	0.44	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	11.04	4.41	0.00	2.21	4.41	2.21	1.10	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.04	4.48	10.25	4.48	3.20	1.28	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	11.90	3.97	4.71	2.73	7.19	0.99	1.24	0.99
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	14.61	8.35	4.18	6.96	3.48	0.00	2.09	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	0.00	8.84	4.42	4.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	8.21	4.44	7.18	5.13	4.44	1.37	2.05	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	11.38	4.81	5.69	5.25	4.38	1.75	1.75	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	15.98	6.75	11.36	6.04	3.55	3.91	1.78	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	9.54	4.49	5.05	3.93	3.37	3.09	2.24	1.68
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	16.63	8.31	4.16	5.40	2.08	2.49	2.08	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	15.15	4.66	6.41	4.08	1.17	2.91	1.75	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	12.97	4.22	4.52	3.92	3.02	2.11	1.81	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	16.28	7.10	7.10	3.34	4.59	2.50	1.67	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	7.22	28.88	14.44	0.00	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	10.16	9.24	6.46	3.69	3.69	0.92	1.85	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	19.92	8.54	5.12	5.69	2.28	5.69	3.98	1.71
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	13.40	6.08	8.71	5.11	3.18	3.87	2.90	1.52
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	13.73	4.41	4.15	2.07	5.96	2.59	2.07	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	21.45	5.15	3.86	6.01	2.57	2.14	2.57	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	19.06	4.45	5.08	3.18	1.91	0.64	1.91	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	17.88	6.67	2.67	4.00	5.07	3.20	4.00	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	15.27	7.48	3.59	6.59	3.89	3.29	3.29	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	8.62	3.96	6.92	5.93	1.70	2.40	1.41	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	11.47	5.10	3.82	4.14	3.19	1.27	2.23	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	15.04	5.97	3.98	5.31	3.32	4.86	4.64	1.55
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	11.76	4.93	8.34	5.31	2.65	1.14	2.65	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	13.92	5.40	2.27	2.84	7.95	1.99	7.10	1.70
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	13.27	6.88	2.46	2.46	3.44	3.44	4.42	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	14.99	6.52	7.82	7.82	0.65	0.65	1.30	1.30
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	7.94	6.17	5.29	2.65	2.65	1.18	2.94	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	14.13	6.34	2.88	5.48	2.59	2.59	4.61	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	24.32	12.36	6.59	8.66	0.82	2.06	5.36	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	18.16	6.85	2.98	4.76	2.08	1.79	4.17	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	7.53	7.53	3.77	0.00	0.00	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	17.82	10.69	3.56	3.56	1.78	5.35	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	28.59	13.80	5.59	4.60	4.27	5.26	3.61	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	9.47	9.47	2.10	1.05	1.05	2.10	4.21	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	37.76	21.15	4.94	4.15	3.36	6.92	5.34	1.58
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	22.35	10.24	3.73	3.73	3.73	1.86	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	20.65	12.39	5.63	5.63	4.13	3.38	3.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	17.05	11.72	1.07	3.20	2.13	2.66	2.40	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	24.20	10.97	4.30	2.38	1.81	4.18	3.28	1.58
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	20.63	8.10	3.68	5.16	5.16	2.21	2.95	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	30.78	15.39	7.33	5.13	5.13	2.20	3.66	1.10
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	38.89	10.89	9.33	9.33	6.22	3.11	7.78	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	20.84	9.09	5.34	2.14	1.60	4.28	1.60	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	34.78	3.86	0.00	3.86	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	27.27	7.07	6.06	3.03	2.02	2.02	3.03	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	10.96	5.90	2.95	2.11	1.26	0.42	1.69	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	29.96	21.79	8.17	4.09	5.45	24.51	6.81	9.53
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	27.34	12.72	4.45	1.27	5.09	12.72	2.54	3.18
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	15.39	10.53	2.43	0.81	6.48	16.20	2.43	4.86
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	18.13	10.57	12.08	4.53	4.53	15.10	1.51	6.04
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	131.33	137.04	102.78	62.81	45.68	216.99	5.71	39.97
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	61.99	52.20	16.31	26.10	16.31	218.58	6.52	61.99
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	38.02	0.00	9.50	9.50	95.05	4.75	23.76
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	37.65	112.94	62.75	0.00	25.10	0.00	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	4.52	0.22	1.29	1.08	0.22	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	3.66	0.52	1.57	0.52	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	4.00	0.67	2.67	3.34	2.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	3.34	2.50	2.09	2.09	0.83	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	3.80	3.23	4.75	1.90	0.95	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	9.58	0.00	11.17	9.58	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	3.40	0.68	0.68	1.36	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	12.86	1.84	0.00	9.19	3.68	0.00	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	3.77	1.67	2.93	1.67	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	6.28	3.25	1.86	1.39	1.39	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	5.13	1.08	3.24	4.59	1.35	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	10.30	2.94	3.99	2.52	0.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	11.13	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	2.98	2.98	1.49	1.49	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	8.66	2.44	1.89	2.17	1.08	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	7.48	2.95	1.36	2.04	1.36	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	5.06	1.96	2.29	2.61	0.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	11.12	5.29	3.10	2.73	0.91	0.18	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	5.30	2.65	2.12	0.53	0.53	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	5.40	3.60	1.80	1.20	1.20	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	10.83	6.24	4.27	1.64	0.98	0.33	1.31	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	6.02	3.42	3.42	3.42	0.98	0.16	0.16	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	19.58	7.23	3.70	4.41	1.59	0.18	0.35	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	5.63	3.52	1.41	1.41	1.41	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	7.82	5.52	2.30	1.38	0.92	0.92	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	9.00	2.57	2.57	0.96	1.61	0.00	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	8.28	8.62	3.10	1.72	1.03	0.34	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	15.17	7.59	17.70	10.11	2.53	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	14.48	6.02	4.68	5.35	1.34	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	6.35	1.69	2.12	2.54	1.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	8.54	5.70	2.14	2.14	0.24	0.47	0.24	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	6.01	3.86	3.86	1.72	2.15	0.43	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	36.11	0.00	0.00	9.03	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	6.33	3.33	4.33	1.67	0.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	13.08	5.86	5.86	3.16	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	4.76	1.98	2.78	0.40	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	13.00	2.79	2.79	0.00	0.93	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	6.81	3.41	4.16	2.65	0.76	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	5.54	2.28	1.30	0.33	0.98	0.00	0.33	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	4.36	4.36	3.92	5.23	0.87	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	12.21	4.98	4.52	3.17	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	2.65	2.65	3.53	2.65	1.76	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	14.63	6.65	3.99	0.66	5.32	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	13.39	0.99	1.98	2.98	0.99	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	4.21	1.91	2.30	3.83	1.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	8.17	3.02	5.14	4.23	2.12	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	12.16	3.76	3.76	2.43	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	11.52	6.10	2.71	0.68	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	20.44	5.11	0.00	0.00	5.11	5.11	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	7.93	1.83	2.44	1.22	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	4.72	1.26	3.46	1.89	0.31	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	9.38	3.03	3.93	3.63	0.30	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	7.12	3.96	3.96	1.58	0.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	11.34	4.53	6.80	3.40	1.13	2.27	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	5.06	0.00	5.06	0.00	5.06	0.00	5.06
Myoblast, donor1	11241-116D8	9.19	2.61	1.86	1.61	1.61	0.50	0.37	0.25
Myoblast, donor2	11322-117D8	10.55	4.79	2.49	3.26	1.73	0.00	0.58	0.00
Myoblast, donor3	11398-118D3	19.17	5.55	5.72	2.69	1.68	1.51	0.17	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	6.71	6.42	6.71	4.38	7.15	0.29	0.29	0.44
Natural Killer Cells, donor1	11230-116C6	26.14	13.53	10.46	2.77	13.84	4.61	10.46	5.54
Natural Killer Cells, donor2	11311-117C6	14.47	12.06	8.14	4.52	15.08	2.41	4.52	2.71
Natural Killer Cells, donor3	11387-118C1	15.46	15.64	13.99	3.87	11.96	1.29	5.52	2.21
Neural stem cells, donor1	11275-116H6	5.81	3.27	6.90	9.44	2.90	0.00	0.00	0.36
Neural stem cells, donor2	11352-117H2	1.93	0.00	7.70	1.93	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	4.55	1.14	1.14	2.28	2.28	0.00	0.00	0.00
Neurons, donor2	11574-120E8	0.88	0.66	1.76	0.44	0.66	0.00	0.00	0.00
Neurons, donor3	11655-122E8	4.11	1.64	1.64	3.29	1.64	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	7.42	6.50	77.02	28.77	11.14	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	2.90	28.99	28.99	11.60	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	15.27	10.38	171.65	59.25	26.88	0.00	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	10.57	3.80	3.80	4.99	4.16	0.00	0.12	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	4.56	1.30	1.63	3.58	2.28	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	3.61	1.60	1.60	2.61	0.60	0.00	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	11.98	4.82	2.34	1.10	0.69	0.14	0.00	0.00
Olfactory epithelial cells, donor2	11934-125I8	14.04	4.63	4.63	1.30	1.74	0.29	0.29	0.14
Olfactory epithelial cells, donor3	11935-125I9	18.96	8.97	3.63	2.04	2.84	0.23	0.11	0.11
Olfactory epithelial cells, donor4	11936-126A1	24.35	12.66	4.97	3.80	2.53	0.10	0.58	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	13.24	3.61	3.61	5.42	1.20	2.41	2.41	0.00
Osteoblast - differentiated, donor1	11276-116H7	3.40	1.49	0.85	1.28	0.64	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	3.43	0.00	1.14	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	2.48	1.24	0.62	3.10	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	1.76	0.98	0.98	0.98	0.98	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	2.81	0.70	4.21	2.81	2.81	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	3.73	0.36	3.55	1.96	1.24	0.00	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	10.11	4.38	3.20	1.68	1.18	0.17	0.25	0.00
Pericytes, donor1	11491-119E6	4.12	2.78	3.34	3.78	1.11	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	4.30	1.58	1.58	3.85	2.04	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	9.36	3.05	3.46	2.44	3.26	0.41	0.00	0.00
Perineurial Cells, donor1	11499-119F5	9.38	2.94	1.24	1.24	1.24	0.23	0.57	0.00
Perineurial Cells, donor2	11579-120F4	14.45	4.97	7.08	4.42	2.48	0.18	0.37	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	41.75	29.01	12.75	6.06	10.84	5.10	15.94	3.82
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	15.92	12.73	7.10	7.59	8.57	1.47	5.14	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	18.25	9.84	9.58	4.01	9.32	1.55	5.18	0.91
Placental Epithelial Cells, donor1	11278-116H9	2.15	2.63	0.48	1.43	0.48	0.00	0.24	0.24
Placental Epithelial Cells, donor2	11355-117H5	6.65	4.44	1.11	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	3.73	0.59	1.37	0.79	0.00	0.39	0.79	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	6.33	1.58	1.90	0.32	0.63	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	12.38	6.00	3.00	1.69	2.25	0.00	0.75	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	21.93	9.14	5.09	3.52	3.13	0.52	0.39	0.00
Preadipocyte - breast, donor2	11328-117E5	6.75	5.85	2.25	2.25	1.35	0.23	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	18.54	12.25	3.41	2.66	3.84	0.85	0.32	0.21
Preadipocyte - omental, donor2	11329-117E6	17.02	2.62	6.55	3.93	3.06	0.44	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	13.75	5.16	2.86	2.29	1.43	0.14	0.29	0.00
Preadipocyte - perirenal, donor1	11469-119C2	6.89	6.89	0.98	0.00	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	2.46	0.31	1.84	0.61	0.92	0.00	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	7.61	2.48	2.48	3.01	1.24	0.35	0.00	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	3.75	1.70	1.53	1.53	1.02	0.17	0.34	0.00
Preadipocyte - visceral, donor1	11280-116I2	11.27	3.54	3.91	3.54	1.77	0.00	0.47	0.00
Preadipocyte - visceral, donor2	11357-117H7	10.58	3.22	0.46	2.76	0.92	0.00	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	7.42	2.09	2.61	2.93	0.42	0.10	0.00	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	11.31	6.03	8.30	1.51	2.11	1.51	0.75	1.06
Prostate Epithelial Cells, donor2	11331-117E8	12.46	5.55	2.30	1.35	2.03	1.76	1.76	0.68
Prostate Epithelial Cells, donor3	11404-118D9	13.10	6.43	2.45	0.98	0.92	0.37	0.06	0.06
Prostate Stromal Cells, donor1	11254-116F3	4.90	2.28	1.94	1.37	0.57	0.23	0.23	0.46
Prostate Stromal Cells, donor2	11332-117E9	6.28	1.26	0.54	2.33	1.61	0.54	0.18	0.00
Prostate Stromal Cells, donor3	11405-118E1	5.11	3.34	2.40	1.04	1.04	0.31	0.52	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	20.07	7.30	2.19	2.92	2.19	1.46	1.09	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	19.34	9.15	2.50	2.63	1.73	1.59	1.32	1.39
Renal Epithelial Cells, donor1	11517-119H5	17.25	4.06	4.06	3.55	0.51	0.00	0.00	1.01
Renal Epithelial Cells, donor2	11597-120H4	11.38	6.40	2.13	2.85	2.85	1.42	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	18.31	8.15	2.33	2.54	2.54	2.75	2.54	2.54
Renal Glomerular Endothelial Cells, donor1	11514-119H2	23.15	9.53	6.81	2.72	1.36	0.68	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	14.82	6.06	6.60	3.37	3.64	2.56	1.21	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	11.32	6.22	7.10	4.44	4.88	0.44	0.89	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	15.31	6.65	4.66	0.67	4.66	0.00	1.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	6.16	3.96	3.74	2.42	1.32	0.22	0.00	0.22
Renal Mesangial Cells, donor2	11598-120H5	10.03	3.13	6.27	5.02	1.25	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	4.16	2.77	0.83	1.66	0.28	0.00	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	30.06	10.47	2.68	3.22	2.95	2.68	1.88	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	14.76	10.12	2.11	2.95	2.11	2.53	0.84	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	9.26	5.79	2.51	2.51	2.31	0.19	0.39	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	6.74	3.11	4.93	2.85	0.78	0.00	0.52	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	7.96	4.83	2.84	1.99	0.57	0.00	0.85	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	3.09	0.00	2.06	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	3.26	2.51	3.01	1.51	0.25	0.00	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	218.36	124.28	25.79	14.43	6.82	41.83	14.30	8.02
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	10.72	6.25	8.04	7.15	3.57	0.00	1.79	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	7.15	4.95	7.71	7.15	7.71	4.40	2.20	2.75
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	13.34	8.70	16.24	12.18	4.06	2.32	5.80	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	8.06	4.81	14.95	7.80	3.51	0.78	0.91	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	5.76	6.26	10.63	6.75	1.99	0.40	0.99	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	9.26	6.58	11.60	7.70	3.46	1.67	1.12	1.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	6.82	5.09	11.66	6.20	4.34	2.73	1.36	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	8.04	4.78	9.91	6.53	3.85	0.35	1.52	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	12.25	9.01	13.17	6.24	3.93	2.08	1.39	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	7.80	3.42	11.91	6.43	2.74	1.23	0.41	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	6.05	5.14	11.19	6.35	3.63	1.82	1.82	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	10.03	7.71	9.68	3.40	4.48	1.79	1.61	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	8.03	4.73	11.91	7.03	3.01	0.72	0.14	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	4.29	3.97	8.37	5.04	3.22	0.21	0.64	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	5.97	7.08	11.06	7.08	4.43	0.44	1.99	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	7.46	3.25	13.00	4.21	2.10	1.34	0.19	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	5.59	4.10	11.18	6.71	2.70	1.30	1.02	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	12.21	10.52	12.40	6.76	6.39	2.25	2.44	1.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	5.84	3.45	13.40	6.50	1.99	0.80	1.06	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	6.33	6.04	12.17	7.11	2.73	1.46	1.46	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	7.45	7.64	11.65	6.30	4.96	0.76	2.29	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	6.94	3.20	12.82	6.30	1.50	0.53	0.64	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	7.29	5.89	9.25	5.89	4.48	1.12	2.24	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	8.37	5.81	13.84	5.98	2.91	1.54	1.03	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	7.11	2.92	13.31	6.75	2.19	0.73	0.55	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	5.40	5.52	10.42	4.78	2.70	1.23	1.47	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	6.85	5.51	10.75	7.25	3.49	1.07	0.54	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	7.78	3.30	13.21	4.25	1.65	0.94	0.24	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	4.76	4.17	11.31	5.16	2.78	0.99	0.79	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	7.95	5.61	11.22	5.38	4.91	2.34	0.94	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	7.88	3.73	11.40	3.53	2.49	0.62	0.41	1.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	5.09	3.76	8.18	5.97	3.54	1.33	0.44	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	12.12	8.77	11.91	6.27	3.76	1.25	0.42	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	9.69	4.98	16.69	7.54	4.58	1.08	0.13	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	4.77	5.45	18.05	5.79	3.58	1.36	2.38	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	10.03	5.40	14.46	10.60	4.24	1.16	1.16	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	12.55	4.99	18.91	8.08	6.19	1.55	0.69	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	9.33	5.08	18.24	8.92	4.25	0.69	0.96	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	12.31	8.04	17.24	9.69	5.25	1.48	2.46	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	9.71	7.16	17.38	5.97	4.43	0.34	0.85	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	8.43	6.81	18.79	7.40	2.81	1.92	1.63	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	15.46	8.53	16.26	9.33	5.33	0.53	1.33	3.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	6.91	4.01	10.78	7.88	2.35	0.69	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	6.90	5.00	12.86	3.81	3.10	0.71	1.90	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	27.41	18.14	23.38	11.49	8.26	1.81	2.22	2.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	9.61	6.31	9.51	7.91	2.17	1.04	0.66	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	9.43	8.04	12.93	5.94	7.34	1.05	1.05	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	9.67	6.95	13.60	6.65	5.74	0.60	0.91	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	7.71	5.26	9.67	5.39	2.81	0.86	0.49	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	28.82	19.80	23.73	18.78	8.59	4.51	7.13	4.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	9.73	7.30	7.91	3.65	2.43	1.83	1.83	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	7.53	2.41	9.04	3.62	1.81	0.60	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	6.33	7.24	12.67	6.56	5.43	0.90	0.68	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	15.58	10.78	11.68	7.79	4.49	2.10	1.20	3.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	9.80	5.67	10.39	8.38	4.37	0.59	0.94	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	11.53	5.34	10.46	7.26	3.84	0.85	0.85	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	15.02	7.21	13.82	13.82	2.40	1.80	1.80	2.40
Schwann Cells, donor1	11498-119F4	6.58	2.63	3.01	4.33	0.38	0.00	0.38	0.19
Schwann Cells, donor2	11578-120F3	10.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	7.45	1.53	2.41	1.53	0.66	0.22	0.22	0.00
Sebocyte, donor1	11220-116B5	33.41	13.15	7.67	5.48	1.10	3.29	4.93	1.10
Sebocyte, donor2	11301-117B5	9.65	5.06	2.76	0.46	0.46	0.92	0.46	0.00
Sebocyte, donor3	11378-118B1	11.54	4.74	0.00	1.03	1.24	0.82	0.00	0.41
Sertoli Cells, donor1	11255-116F4	19.88	3.31	8.28	3.31	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	14.12	0.00	0.00	0.00	2.82	0.00	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	4.05	0.88	1.58	2.02	0.97	0.00	0.18	0.00
Skeletal Muscle Cells, donor2	11358-117H8	2.89	2.17	0.72	2.89	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	6.69	6.69	0.84	0.84	1.67	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	7.23	3.14	2.36	3.14	1.73	0.00	0.00	0.16
Skeletal Muscle Cells, donor5	11455-119A6	10.11	4.61	2.08	2.82	1.34	0.30	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	10.16	2.77	3.08	4.62	0.62	0.00	0.00	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	16.38	8.44	5.04	5.42	3.53	0.38	1.13	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	10.70	5.42	3.85	3.42	1.43	0.14	0.14	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	10.22	4.17	2.78	3.67	1.79	0.20	0.60	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	6.07	2.36	3.20	1.43	1.35	0.17	0.42	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	2.90	2.17	1.45	2.17	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	2.34	0.55	1.65	1.10	0.14	0.00	0.00	0.00
Skin - palm, donor1	10286-104F7	75.21	67.15	51.04	37.61	5.37	10.74	8.06	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	14.13	5.48	1.01	0.86	1.01	1.87	0.86	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	263.36	65.43	17.18	5.73	13.90	34.35	7.36	9.81
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	12.46	3.89	0.65	0.78	0.52	1.04	0.65	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	13.62	7.51	2.09	0.97	1.39	1.25	0.83	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	14.49	7.88	3.09	1.83	0.84	0.98	0.56	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	133.21	41.23	17.34	7.82	8.67	24.74	12.69	9.94
Small Airway Epithelial Cells, donor3	11406-118E2	12.37	9.97	2.55	2.10	1.87	0.45	0.30	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	4.94	1.23	1.54	2.78	0.62	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	9.78	7.11	2.00	4.00	2.45	0.44	0.44	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	8.23	3.53	2.35	0.59	3.53	0.59	1.18	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	6.41	3.76	1.33	1.55	1.55	0.44	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	5.12	2.76	0.79	0.79	2.36	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	9.27	3.09	3.09	3.09	2.32	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	2.00	3.00	4.00	2.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	4.79	1.86	1.06	1.46	1.33	0.13	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	5.54	2.22	0.66	0.89	0.66	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	4.99	1.54	1.54	2.69	0.13	0.00	0.26	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	9.44	4.88	1.63	3.26	3.26	0.65	1.95	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	10.93	3.84	5.61	3.25	3.25	0.00	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	15.80	6.83	6.55	3.56	2.99	0.43	0.57	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	7.00	1.46	1.14	0.49	1.46	0.16	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	7.92	4.57	2.44	2.44	0.91	0.30	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	10.36	4.04	0.51	0.51	1.26	0.00	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	1.43	0.48	0.48	3.34	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	14.01	5.01	6.05	3.10	2.21	0.44	0.88	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	6.24	5.60	5.60	3.44	3.66	0.22	0.65	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	11.23	4.30	4.20	2.83	1.36	0.31	0.10	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	6.34	2.17	1.70	1.24	1.55	0.46	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	5.39	1.08	4.31	2.16	1.08	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	4.78	2.99	3.89	3.59	1.49	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	10.58	4.10	4.10	3.41	1.37	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	14.76	9.89	5.89	1.73	1.57	0.00	0.39	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	4.73	3.32	2.82	2.72	1.11	0.20	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	11.15	4.10	1.82	1.59	3.87	0.00	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	3.62	1.81	1.81	1.21	1.21	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	12.19	4.77	4.50	2.91	1.85	1.32	0.53	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	7.06	1.20	4.13	2.93	0.80	0.13	0.00	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	4.51	2.50	4.26	1.25	0.63	0.13	0.00	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	7.36	2.79	3.04	2.03	2.03	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	7.84	3.62	1.81	1.51	1.06	0.15	0.15	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	6.75	1.50	1.50	1.50	2.25	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	5.17	3.88	3.88	0.00	1.29	0.00	1.29	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	4.19	1.86	2.33	1.40	0.47	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	5.55	4.54	1.01	2.02	1.51	0.00	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	8.46	3.45	0.31	0.94	1.25	0.00	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	5.31	1.77	0.29	1.18	1.47	0.00	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	8.75	3.17	2.17	4.08	2.33	0.00	0.42	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	7.94	2.34	2.34	2.80	2.34	0.00	0.47	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	3.17	2.59	2.88	1.15	1.01	0.14	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	5.10	2.80	3.31	1.02	1.27	0.00	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	2.07	0.75	3.38	2.07	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	8.80	4.19	3.63	1.12	1.26	0.14	0.00	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	7.71	2.68	2.51	1.01	0.67	0.00	0.08	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	25.24	12.38	1.90	0.48	0.00	0.00	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	3.43	1.22	5.14	1.71	0.73	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	5.52	2.43	2.43	1.55	1.10	0.44	0.44	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	6.44	2.63	1.17	1.17	0.29	0.59	0.59	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	5.64	1.75	3.69	2.72	0.39	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	16.13	7.40	2.64	2.12	3.17	0.53	0.53	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	4.46	1.86	2.23	1.12	0.74	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	12.22	8.98	1.08	2.16	1.08	0.36	0.36	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	17.03	6.25	4.26	1.42	1.70	0.57	0.00	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	5.51	2.76	2.36	1.58	1.58	0.00	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	8.13	4.57	1.52	1.78	2.29	0.25	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	7.19	3.59	2.00	2.00	0.80	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	4.18	3.76	0.42	0.84	2.51	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	5.04	4.58	3.67	1.83	0.00	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	8.42	4.71	1.35	0.50	0.84	0.00	0.17	0.00
Synoviocyte, donor2	11368-117I9	6.87	3.52	1.17	1.68	1.34	0.00	0.00	0.00
Synoviocyte, donor3	11440-118H9	6.70	4.02	0.89	1.56	1.56	0.00	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	8.22	5.36	3.22	1.43	0.36	0.00	0.36	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	13.87	3.96	5.95	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	7.41	3.24	5.33	2.78	0.00	0.23	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	9.53	3.87	1.22	0.86	1.15	0.65	0.79	0.43
Tracheal Epithelial Cells, donor2	11369-118A1	8.12	2.71	1.16	1.16	0.39	0.39	0.39	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	6.87	5.73	1.72	0.00	0.57	0.57	0.57	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	226.61	116.50	26.70	15.75	8.37	45.64	15.26	8.73
Urethra, donor2	10319-105A4	25.18	32.37	46.76	23.38	5.40	10.79	0.00	1.80
Urothelial Cells, donor1	11520-119H8	12.22	5.58	4.25	2.13	1.33	1.59	0.80	0.27
Urothelial Cells, donor2	11600-120H7	17.22	2.80	1.20	1.60	1.60	0.80	0.40	0.00
Urothelial Cells, donor3	11681-122H7	10.31	3.44	3.21	1.15	1.38	0.23	0.46	0.69
Urothelial cells, donor0	11216-116B1	18.05	7.36	5.80	2.90	1.11	2.01	1.56	1.11
Whole blood (ribopure), donor090309, donation1	12179-129A1	16.02	5.34	49.83	30.25	8.01	0.00	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	21.44	8.58	65.76	32.88	20.01	1.43	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	8.90	5.48	30.80	25.33	11.64	0.68	1.37	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	21.69	16.87	17.91	9.99	9.99	1.72	7.92	2.07
Whole blood (ribopure), donor090325, donation2	12177-128I8	19.17	13.94	17.43	9.88	13.36	1.74	8.72	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	16.66	4.16	49.98	17.70	11.45	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	20.19	10.10	37.63	22.03	17.44	0.92	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	7.30	7.30	31.04	25.56	10.04	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	2.34	1.11	1.85	1.11	0.25	0.00	0.12	0.00
Wilms' tumor cell line:HFWT	10597-108E3	15.84	8.80	1.76	5.28	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	13.69	8.66	7.82	1.68	1.12	1.40	0.56	1.40
achilles tendon, donor2	10292-104G4	35.13	14.47	26.86	33.06	0.00	2.07	6.20	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	7.90	9.94	8.67	4.59	5.10	5.61	5.35	3.82
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	12.31	8.59	6.27	2.09	15.09	5.57	8.13	7.66
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	33.00	20.06	9.14	8.43	21.25	3.21	5.46	1.90
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	14.69	4.90	2.18	1.90	11.16	0.54	0.82	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	13.77	10.96	5.34	1.12	5.06	5.62	2.53	4.22
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	9.52	4.02	6.34	2.75	9.94	1.48	0.85	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	13.07	10.89	11.98	5.17	6.26	5.17	1.36	5.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	9.69	4.41	5.73	5.29	9.25	0.44	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	14.70	9.39	11.43	6.94	10.21	2.45	2.45	2.45
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	56.30	27.57	10.87	8.54	28.35	29.12	11.26	6.99
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	13.25	9.57	10.49	3.13	5.89	1.29	1.47	1.29
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	58.51	19.50	23.40	15.60	0.00	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	24.17	11.62	5.11	5.58	13.48	4.42	3.02	2.79
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	52.30	27.70	19.68	8.80	60.32	31.84	8.28	16.57
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	53.19	25.13	16.95	11.69	30.98	12.27	6.43	7.01
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	38.58	11.62	9.76	6.04	12.55	15.34	2.32	12.55
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	38.25	15.63	12.75	6.58	16.86	2.88	2.06	3.70
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	24.86	6.45	8.29	9.52	11.36	3.07	0.61	1.84
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	32.00	14.08	13.23	13.23	12.37	10.67	5.55	5.97
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	34.27	20.32	18.50	6.37	8.19	13.34	5.46	8.19
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	39.96	17.33	16.13	6.98	13.24	9.87	6.50	5.30
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	20.71	11.58	5.12	3.56	6.90	4.45	0.67	1.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	26.35	9.67	10.67	14.34	8.67	3.00	3.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	40.88	29.73	37.16	13.01	5.57	3.72	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	17.33	6.40	18.46	4.90	13.56	3.39	3.77	2.26
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	18.75	4.80	23.12	9.59	5.23	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	11.25	5.62	15.00	0.00	5.62	9.37	13.12	3.75
adenocarcinoma cell line:IM95m	10796-110I4	7.30	14.60	13.89	3.53	2.12	0.00	0.24	0.47
adipose tissue, adult, pool1	10010-101C1	68.41	26.99	38.62	25.90	16.91	6.83	6.67	4.19
adipose, donor1	10184-103D4	17.01	14.66	35.18	11.14	1.17	1.76	0.00	1.17
adipose, donor2	10185-103D5	5.27	2.03	15.41	6.08	0.41	0.41	0.41	0.00
adipose, donor3	10186-103D6	8.17	7.08	13.89	6.81	1.63	1.09	0.00	0.54
adipose, donor4	10187-103D7	15.60	15.60	6.93	6.93	0.00	0.87	1.73	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	3.95	0.47	1.26	4.58	1.10	0.00	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	18.19	3.64	29.10	32.74	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	10.27	8.54	8.40	6.67	4.80	1.60	1.60	2.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	6.43	3.93	2.86	2.14	2.50	0.00	0.36	1.07
amniotic membrane cells, donor1	12235-129G3	22.26	13.45	3.71	0.93	0.93	7.42	5.33	4.87
amniotic membrane cells, donor2	12236-129G4	10.14	3.38	2.03	1.35	2.37	1.35	4.40	0.68
amniotic membrane cells, donor3	12237-129G5	13.26	6.19	2.65	1.47	0.29	3.54	6.48	2.06
amygdala - adult, donor10196	10167-103B5	21.34	8.30	10.67	4.74	2.37	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	19.87	9.33	13.99	11.96	6.29	0.61	1.62	0.41
amygdala, newborn, donor10223	10360-105E9	8.39	7.75	6.13	6.78	1.61	0.65	0.32	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	30.56	20.63	10.70	4.07	7.26	2.42	1.91	1.53
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	9.05	5.52	2.21	1.32	1.32	0.44	0.44	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	0.33	0.67	10.69	3.67	1.34	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	33.73	21.18	22.16	17.06	7.06	1.37	2.35	0.59
appendix, adult	10189-103D9	31.83	18.63	22.51	8.15	6.99	4.27	5.05	3.49
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	6.19	7.22	16.51	3.78	0.69	0.00	0.00	0.00
artery, adult	10190-103E1	23.10	78.80	48.91	10.87	10.87	1.36	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	1.74	1.45	3.77	1.45	0.29	0.14	0.14	0.14
b cell line:RPMI1788	10427-106D4	13.09	10.26	13.09	9.52	13.09	14.42	10.11	10.41
basal cell carcinoma cell line:TE 354.T	10702-109G9	16.92	5.27	2.50	2.50	0.83	0.00	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	9.43	5.85	4.96	2.18	3.18	4.37	2.58	2.18
bile duct carcinoma cell line:TFK-1	10496-107C1	21.09	19.92	7.70	3.35	2.85	7.36	1.67	3.68
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	25.72	14.54	16.78	2.80	7.83	2.24	2.80	1.12
bladder, adult, pool1	10011-101C2	43.46	20.53	24.88	14.01	5.65	4.67	4.45	2.50
blood, adult, pool1	10053-101G8	13.29	6.64	8.86	8.86	4.43	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	36.82	10.28	2.57	5.14	0.86	0.00	0.86	0.86
bone marrow, adult	10192-103E3	35.77	20.24	26.99	17.55	12.82	6.75	1.35	0.67
brain, adult, donor1	10084-102B3	9.23	5.13	8.20	10.25	1.03	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	11.25	7.24	5.68	6.35	3.56	0.00	0.45	0.00
brain, fetal, pool1	10085-102B4	5.34	2.67	2.67	5.34	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	5.62	6.61	4.63	2.31	2.31	0.00	0.99	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	19.60	16.73	19.47	3.50	2.75	3.25	3.25	2.00
breast, adult, donor1	10080-102A8	46.72	21.47	32.20	17.68	6.94	5.68	3.16	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	7.62	1.27	0.76	1.78	0.38	1.78	1.02	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	16.08	12.99	12.99	4.64	2.47	7.11	4.95	5.26
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	5.30	2.30	1.15	0.69	1.15	1.15	1.84	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	5.57	8.72	0.73	0.73	0.73	0.97	2.42	1.21
carcinoid cell line:NCI-H1770	10703-109H1	8.93	5.64	12.22	2.82	4.70	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	12.47	8.09	9.52	2.73	1.20	2.63	1.20	3.28
carcinoid cell line:SK-PN-DW	10719-109I8	12.04	10.14	1.90	2.22	6.02	0.00	0.00	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	5.06	5.59	23.42	17.30	6.65	0.00	0.00	0.00
caudate nucleus - adult, donor10196	10177-103C6	31.09	18.42	16.12	14.97	8.06	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	17.74	11.21	7.03	10.88	8.20	0.67	1.51	0.33
caudate nucleus, adult, donor10258	10379-105H1	15.28	9.17	5.35	7.64	0.76	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	11.35	11.72	4.39	8.06	4.76	0.73	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	11.65	8.74	20.39	14.57	0.00	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	16.23	12.38	25.19	15.80	3.63	0.64	0.43	0.43
cerebellum, adult, pool1	10083-102B2	4.83	5.52	5.52	6.90	0.34	0.00	1.72	0.00
cerebellum, newborn, donor10223	10357-105E6	6.64	9.13	19.10	13.28	3.32	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	10.34	9.33	7.31	7.82	2.27	0.25	0.50	0.25
cerebrospinal fluid, donor2	10294-104G6	9.50	21.93	35.81	8.04	0.73	0.73	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	10.50	10.93	5.75	2.59	2.44	0.86	1.01	1.87
cervical cancer cell line:ME-180	10553-107I4	6.96	4.64	6.46	1.49	1.82	0.17	0.00	0.00
cervix, adult, pool1	10013-101C4	52.81	25.62	34.23	18.27	8.92	6.51	4.72	5.77
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	8.50	4.88	2.09	1.95	2.51	0.98	0.42	0.98
chondrosarcoma cell line:SW 1353	10700-109G7	20.90	15.68	6.53	7.84	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	13.30	9.57	2.24	1.24	0.37	5.59	2.86	3.60
choriocarcinoma cell line:SCH	10785-110H2	16.26	6.53	3.57	2.96	0.74	2.96	1.23	1.23
choriocarcinoma cell line:T3M-3	10618-108G6	10.44	6.17	2.13	2.13	0.24	0.71	1.90	0.47
chorionic membrane cells, donor1	12238-129G6	52.43	18.80	3.70	1.71	0.57	22.79	5.41	11.11
chorionic membrane cells, donor2	12239-129G7	15.91	6.66	5.47	3.78	2.09	2.78	1.99	0.99
chorionic membrane cells, donor3	12240-129G8	46.16	26.92	6.59	1.65	1.10	35.72	7.14	10.99
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	5.05	5.05	1.01	1.01	2.02	0.00	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	10.95	7.68	14.02	6.92	12.68	1.34	1.73	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	26.61	12.04	39.70	6.34	7.18	14.36	10.98	8.45
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	11.56	3.85	12.58	7.45	1.80	0.77	1.28	1.54
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	12.58	3.87	20.56	6.05	3.14	1.21	1.21	3.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	12.62	3.26	17.31	10.38	2.04	1.63	1.43	3.05
chronic myelogenous leukemia cell line:K562	10454-106G4	11.78	5.59	28.27	10.01	2.94	5.01	2.36	5.30
chronic myelogenous leukemia cell line:KU812	10409-106B4	44.83	18.50	34.66	13.29	31.28	38.57	30.49	17.72
clear cell carcinoma cell line:JHOC-5	10638-108I8	29.26	14.40	3.43	1.60	2.51	2.06	1.60	2.06
clear cell carcinoma cell line:TEN	10636-108I6	16.66	11.97	7.11	3.12	3.99	5.03	2.95	5.21
colon carcinoma cell line:CACO-2	10513-107D9	6.22	6.77	11.17	2.56	0.73	1.28	0.73	0.73
colon carcinoma cell line:COLO-320	10420-106C6	68.79	41.81	12.92	4.94	3.04	1.90	3.04	1.14
colon, adult, donor1	10082-102B1	29.75	19.04	35.70	19.04	3.57	1.19	2.38	1.19
colon, adult, pool1	10014-101C5	43.12	24.09	35.13	16.33	8.70	4.35	4.35	4.47
colon, fetal, donor1	10070-101I7	32.75	18.54	29.05	21.63	6.80	3.09	1.24	2.47
common myeloid progenitor CMP, donor1	12130-128D6	279.59	119.17	50.42	55.00	36.67	18.33	27.50	9.17
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	2.97	0.85	6.80	4.25	6.37	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	2.72	1.66	3.92	2.26	1.96	0.00	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	2.26	1.69	5.22	4.51	2.40	0.00	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	25.10	16.69	20.45	16.69	5.97	0.33	1.66	0.55
cruciate ligament, donor2	10295-104G7	30.80	21.07	49.44	25.94	9.73	6.48	4.05	1.62
diaphragm, fetal, donor1	10069-101I6	34.51	50.56	62.60	13.64	7.22	0.80	0.00	0.80
diencephalon, adult	10193-103E4	10.56	5.76	5.52	4.32	1.44	0.00	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	18.83	16.99	9.87	3.67	8.27	21.58	13.09	18.83
ductal cell carcinoma cell line:KLM-1	10438-106E6	16.67	15.13	4.10	1.80	1.54	3.08	2.82	1.28
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	6.02	3.13	1.93	1.93	0.96	1.20	1.93	0.48
ductus deferens, adult	10196-103E7	31.89	27.41	37.38	15.95	10.96	0.50	1.50	1.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	23.04	18.72	34.57	14.40	7.20	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	31.63	19.13	27.22	14.71	7.36	2.94	2.21	2.21
dura mater, adult, donor1	10041-101F5	27.67	21.89	52.44	19.74	16.02	3.14	2.23	1.90
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	5.55	5.55	3.55	3.33	2.00	1.33	0.00	3.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	9.74	8.17	4.01	2.01	3.30	2.72	1.00	4.44
embryonic pancreas cell line:1B2C6	10604-108F1	4.32	2.47	0.62	1.23	0.62	1.23	1.85	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	6.36	3.03	0.91	0.91	0.30	0.00	1.21	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	5.56	2.47	0.31	2.78	0.62	0.62	0.31	0.31
embryonic pancreas cell line:2C6	10603-108E9	11.82	2.63	2.63	3.94	0.00	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	25.47	15.08	11.06	6.03	16.42	6.03	2.01	2.68
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	9.06	4.89	1.27	2.36	1.45	0.00	0.54	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	6.27	5.79	2.09	1.93	0.48	0.80	0.96	0.00
epidermoid carcinoma cell line:A431	10426-106D3	18.67	10.23	7.45	1.67	2.22	5.45	3.45	3.89
epidermoid carcinoma cell line:Ca Ski	10431-106D8	10.78	5.94	1.43	0.77	1.54	1.54	2.20	1.54
epididymis, adult	10197-103E8	25.12	22.61	35.58	17.58	7.33	1.47	2.93	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	3.37	2.13	0.53	0.18	0.89	0.71	0.71	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	3.15	1.18	1.57	2.75	0.79	0.00	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	23.59	14.42	1.83	1.57	1.70	8.91	6.29	5.24
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	29.33	20.47	4.33	1.77	3.35	7.18	4.33	5.41
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	23.86	10.87	2.46	1.34	1.57	5.71	4.71	4.03
esophagus, adult, pool1	10015-101C6	34.93	19.01	19.01	7.86	2.76	3.82	3.29	1.27
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	0.00	0.00	0.00	0.25	0.25	0.00	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	79.68	45.88	82.10	60.36	14.49	4.83	2.41	2.41
eye - muscle lateral, donor2	10298-104H1	31.56	25.25	35.77	8.42	4.21	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	41.67	44.65	37.21	28.28	10.42	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	32.10	19.49	47.01	33.25	12.61	1.15	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	4.37	8.74	115.13	33.52	1.46	1.46	1.46	0.00
eye, fetal, donor1	10054-101G9	13.47	8.64	62.54	22.63	3.31	0.00	0.51	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	7.69	3.59	2.56	1.54	1.54	0.77	1.28	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	10.45	4.27	4.27	3.56	2.14	2.37	1.19	0.24
frontal lobe, adult, pool1	10040-101F4	12.20	13.04	6.66	7.79	2.44	0.19	0.84	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	5.70	6.61	12.91	2.40	1.50	0.90	2.70	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	24.87	22.58	3.02	3.20	1.65	1.74	4.11	2.10
gall bladder, adult	10198-103E9	20.28	20.76	23.66	14.97	8.69	1.69	2.41	1.45
gamma delta positive T cells, donor1	11937-126A2	21.47	11.81	6.98	2.68	10.74	2.68	6.98	2.15
gamma delta positive T cells, donor2	11938-126A3	18.30	13.45	10.08	3.36	7.10	2.24	5.23	2.61
gastric adenocarcinoma cell line:MKN1	10614-108G2	10.56	7.82	7.18	1.90	3.17	1.27	1.06	1.48
gastric adenocarcinoma cell line:MKN45	10612-108F9	7.35	4.26	5.22	1.16	2.13	1.93	1.16	0.39
gastric cancer cell line:AZ521	10549-107H9	5.90	2.62	2.79	5.41	2.13	0.00	0.00	0.16
gastric cancer cell line:GSS	10560-108A2	7.32	7.32	1.83	1.83	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	8.22	6.85	26.73	9.14	0.46	1.37	1.14	0.46
giant cell carcinoma cell line:LU65	10487-107B1	5.85	4.70	1.03	0.80	1.15	0.34	0.23	0.69
giant cell carcinoma cell line:Lu99B	10433-106E1	10.64	3.50	4.62	1.54	1.82	3.78	2.66	3.22
glassy cell carcinoma cell line:HOKUG	10688-109F4	11.22	5.49	4.24	1.50	2.00	2.00	2.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	7.18	3.59	4.86	2.43	3.17	0.53	1.27	0.84
glioblastoma cell line:A172, tech_rep2	10444-106F3	6.32	4.07	6.18	3.65	2.11	1.26	0.56	0.84
glioblastoma cell line:T98G	10485-107A8	3.42	0.88	4.19	2.21	0.99	0.11	0.22	0.11
glioma cell line:GI-1	10413-106B8	2.64	2.05	4.10	1.17	0.00	0.29	0.29	0.29
globus pallidus - adult, donor10196	10175-103C4	24.78	10.93	14.58	18.95	5.10	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	34.66	18.80	19.04	18.31	8.79	0.73	1.22	0.98
globus pallidus, adult, donor10258	10367-105F7	6.85	5.48	17.80	19.17	1.37	0.00	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	17.05	9.59	6.40	6.40	3.73	1.07	1.07	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	274.08	92.99	41.60	26.92	51.39	19.58	9.79	9.79
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	43.71	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	10.45	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	13.44	5.76	7.04	3.20	1.28	0.96	0.96	0.32
hIPS +CCl2, biol_rep1	14383-156B9	48.67	23.41	9.18	1.38	1.84	3.67	1.38	1.84
hIPS +CCl2, biol_rep2	14384-156C1	50.30	17.83	6.40	4.57	1.83	1.37	0.00	1.37
hIPS +CCl2, biol_rep3	14385-156C2	51.53	28.34	7.09	0.00	1.93	3.22	1.29	2.58
hIPS, biol_rep1	14380-156B6	68.99	18.68	1.44	1.44	2.87	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	34.98	17.15	0.69	0.69	1.37	1.37	0.00	0.69
hIPS, biol_rep3	14382-156B8	18.76	7.72	6.62	6.62	1.10	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	9.19	4.88	4.02	5.17	2.87	0.57	1.44	0.00
heart - mitral valve, adult	10205-103F7	42.75	31.69	33.19	22.12	12.26	0.90	2.09	0.60
heart - pulmonic valve, adult	10206-103F8	33.47	31.64	21.96	19.61	7.84	0.52	1.57	0.78
heart - tricuspid valve, adult	10207-103F9	74.94	42.46	24.15	15.82	14.15	6.66	1.67	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	28.77	22.85	22.24	14.08	2.45	0.41	1.02	0.00
heart, adult, diseased, donor1	10051-101G6	40.88	39.18	37.05	23.42	2.98	0.43	0.00	0.43
heart, adult, pool1	10016-101C7	56.11	37.95	20.93	17.25	4.83	0.46	0.46	0.00
heart, fetal, pool1	10046-101G1	47.34	22.69	47.64	27.62	10.06	1.33	2.05	0.82
hepatic mesenchymal tumor cell line:LI90	10778-110G4	15.43	8.02	9.26	5.86	2.47	0.31	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	14.27	13.08	10.70	5.95	1.19	3.57	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	17.68	15.47	6.74	2.43	0.99	1.22	1.99	1.10
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	15.17	12.74	7.28	2.18	1.58	0.73	1.58	0.85
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	20.11	17.58	6.87	3.33	1.92	1.62	2.32	1.72
hepatoma cell line:Li-7	10484-107A7	5.67	5.89	9.68	3.45	1.78	1.00	0.89	1.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	4.22	3.32	3.62	3.32	3.82	0.60	1.31	1.31
hippocampus - adult, donor10196	10169-103B7	17.98	9.46	16.09	6.62	5.68	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	27.35	16.33	17.55	19.39	11.23	0.20	0.82	0.41
hippocampus, adult, donor10258	10374-105G5	14.44	7.47	2.49	4.48	3.49	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	7.05	5.64	2.82	5.64	2.82	0.35	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	39.67	37.23	12.21	6.10	2.44	2.44	3.66	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	24.35	23.76	10.01	1.57	1.57	0.98	1.57	3.73
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	34.78	28.94	7.62	3.55	2.03	3.55	2.54	2.54
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	23.12	17.48	14.66	3.38	1.13	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	17.56	18.85	16.53	5.68	1.03	0.00	0.52	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	19.36	17.08	18.98	6.83	0.76	0.00	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	8.47	10.22	23.65	10.51	3.80	0.58	0.29	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	11.85	11.20	20.68	11.42	3.23	1.72	1.94	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	10.84	11.68	18.77	10.84	4.59	0.00	0.83	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	5.21	4.50	9.95	3.32	1.66	0.00	0.24	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	5.63	6.75	12.05	6.11	3.38	0.32	0.48	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	10.10	6.73	6.06	8.75	1.35	0.00	0.67	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	24.57	25.98	8.29	2.97	1.25	3.29	2.66	4.23
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	36.85	26.53	9.83	1.47	2.95	1.97	1.97	2.46
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	14.84	19.20	9.60	4.36	1.75	2.62	5.24	8.73
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	15.27	13.55	26.35	8.21	1.15	0.38	0.38	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	11.34	7.85	29.65	7.85	0.87	0.44	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	11.99	9.50	21.99	9.00	0.50	0.00	0.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	5.46	3.39	20.35	9.61	1.32	0.19	0.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	4.55	5.91	16.82	8.18	0.45	0.45	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	6.58	3.76	18.48	10.34	0.63	0.00	0.31	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	4.25	2.94	9.47	4.90	0.82	0.16	0.16	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	7.55	5.52	11.03	4.06	1.16	0.29	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	4.18	3.59	13.15	4.48	0.90	0.00	0.60	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	26.23	29.37	5.54	1.66	1.11	2.03	2.77	2.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	30.81	23.39	6.85	2.28	2.57	0.57	1.14	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	38.38	31.85	8.57	2.04	2.45	2.86	3.27	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	13.38	8.10	19.72	7.75	2.82	0.70	0.00	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	10.14	6.65	17.10	3.48	0.00	0.63	0.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	9.08	6.66	16.64	7.26	0.91	0.61	1.21	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	4.65	4.65	16.03	7.24	2.07	1.03	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	7.31	5.98	9.96	4.65	0.66	0.66	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	4.36	3.59	13.08	7.18	1.54	0.26	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	7.41	4.35	12.53	4.09	1.79	0.26	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	5.30	3.79	17.42	8.33	2.27	0.00	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	6.72	4.03	8.40	5.71	1.34	0.00	1.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	27.05	26.57	5.80	0.72	0.97	1.45	0.48	1.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	24.07	29.41	4.90	1.78	2.23	0.45	1.78	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	27.32	31.22	9.76	3.41	2.93	1.95	1.95	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	18.34	14.98	19.56	6.11	1.22	0.00	0.31	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	45.55	22.77	87.84	6.51	3.25	3.25	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	21.51	18.53	27.14	8.94	1.99	0.33	0.33	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	8.21	5.47	17.51	8.76	1.09	0.00	0.55	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	6.88	5.79	19.18	10.13	0.72	0.36	1.09	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	7.47	6.76	16.73	8.54	1.42	0.36	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	8.35	5.97	14.32	4.77	3.58	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	8.40	7.99	19.23	8.40	3.39	0.41	0.68	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	4.04	7.81	11.05	5.12	1.89	0.27	0.00	0.27
immature langerhans cells, donor1	11904-125F5	11.87	4.84	27.60	9.69	9.44	4.84	1.94	3.15
immature langerhans cells, donor2	11905-125F6	16.63	19.80	18.22	5.54	1.58	15.05	6.34	8.71
insula, adult, pool1	10039-101F3	17.41	13.06	10.41	9.37	3.97	0.19	0.76	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	5.20	2.93	1.95	0.65	0.00	0.33	0.65	0.33
kidney, adult, pool1	10017-101C8	46.06	23.93	31.34	20.13	25.93	6.71	4.31	4.41
kidney, fetal, pool1	10045-101F9	54.25	26.67	37.99	22.64	17.05	5.87	2.55	2.97
large cell lung carcinoma cell line:IA-LM	10509-107D5	29.11	9.37	4.97	2.84	2.13	2.98	5.40	1.56
large cell lung carcinoma cell line:NCI-H460	10839-111E2	0.55	0.28	0.97	0.41	0.55	0.00	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	5.69	4.22	2.57	1.47	1.47	0.73	0.73	0.18
left atrium, adult, donor1	10079-102A7	40.32	34.33	13.08	15.80	2.72	0.00	0.54	0.00
left ventricle, adult, donor1	10078-102A6	24.27	32.87	14.16	11.63	2.02	0.00	1.01	0.00
leiomyoblastoma cell line:G-402	10721-110A1	0.55	0.55	0.27	1.09	0.55	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	2.87	1.80	1.44	0.36	2.16	0.36	0.36	1.08
leiomyoma cell line:15242A	10570-108B3	1.63	2.17	2.72	1.09	1.63	0.54	0.00	1.09
leiomyoma cell line:15425	10571-108B4	5.10	1.70	0.49	2.43	1.46	0.97	0.49	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	12.70	0.00	6.35	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	7.32	9.41	8.36	6.27	7.32	1.05	1.05	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	9.09	2.60	16.53	4.60	4.37	3.66	4.37	4.96
liposarcoma cell line:KMLS-1	10782-110G8	8.44	3.44	3.59	2.50	1.25	0.94	1.72	0.31
liposarcoma cell line:SW 872	10726-110A6	9.99	7.55	7.31	3.17	2.19	0.85	1.83	0.61
liver, adult, pool1	10018-101C9	13.13	10.21	12.96	7.45	1.94	0.65	1.13	0.65
liver, fetal, pool1	10086-102B5	13.17	9.41	13.17	6.58	5.64	0.00	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	25.81	17.64	13.85	14.58	4.52	0.58	0.73	0.44
locus coeruleus, adult, donor10252	10165-103B3	23.07	14.58	11.07	9.23	4.06	0.74	0.37	0.18
locus coeruleus, adult, donor10258	10375-105G6	10.16	4.80	5.64	6.21	2.26	0.00	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	17.25	13.88	5.05	2.94	5.89	3.36	0.84	0.84
lung adenocarcinoma cell line:A549	10499-107C4	24.36	12.18	11.07	7.47	8.03	4.71	4.15	1.80
lung adenocarcinoma cell line:PC-14	10408-106B3	18.61	8.96	3.45	5.52	0.69	5.52	8.27	5.52
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	16.74	15.29	2.77	7.12	1.32	4.09	3.95	2.77
lung, adult, pool1	10019-101D1	47.84	17.48	21.62	15.47	10.51	3.54	7.91	2.95
lung, fetal, donor1	10068-101I5	83.91	21.69	63.36	47.66	17.12	3.14	0.00	2.00
lung, right lower lobe, adult, donor1	10075-102A3	27.95	13.75	26.58	13.75	4.58	0.92	2.29	0.92
lymph node, adult, donor1	10077-102A5	17.04	13.73	9.94	10.89	3.31	3.79	3.79	0.95
lymphangiectasia cell line:DS-1	10727-110A7	16.00	11.40	10.30	6.36	4.82	14.90	8.99	10.74
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	2.57	1.66	2.41	1.21	2.72	1.66	1.51	2.26
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	6.80	4.25	6.80	9.34	5.10	13.59	11.04	11.89
mature adipocyte, donor1	12231-129F8	29.75	22.20	19.98	35.52	5.33	2.66	0.44	0.89
mature adipocyte, donor2	12232-129F9	25.94	16.19	18.26	26.36	6.64	5.81	1.66	2.08
mature adipocyte, donor3	12233-129G1	29.40	18.02	22.76	32.00	6.40	4.03	0.95	3.56
mature adipocyte, donor4	12234-129G2	35.27	28.43	21.58	24.48	7.37	2.63	1.58	2.37
maxillary sinus tumor cell line:HSQ-89	10414-106B9	18.35	14.77	12.87	8.10	1.19	3.10	5.24	3.57
medial frontal gyrus - adult, donor10196	10170-103B8	13.54	13.54	7.90	7.90	1.13	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	22.62	13.43	12.87	13.98	10.48	0.18	0.74	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	6.04	7.94	4.13	6.67	2.86	0.00	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	10.24	5.54	8.96	8.10	4.69	4.69	2.13	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	15.86	10.97	9.11	8.61	6.24	0.34	0.34	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	24.41	19.52	14.01	17.40	9.76	0.64	1.06	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	11.56	9.63	3.85	3.85	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	7.18	2.87	6.82	5.03	4.67	0.36	0.72	1.08
medulla oblongata - adult, donor10196	10174-103C3	30.50	12.33	10.38	11.68	3.24	1.95	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	31.58	17.18	18.27	14.40	5.57	0.15	2.79	0.15
medulla oblongata, adult, pool1	10038-101F2	27.02	16.00	15.75	15.35	5.96	0.73	1.88	0.41
medulla oblongata, newborn, donor10223	10361-105F1	15.62	11.11	9.37	10.76	8.68	0.00	0.00	0.35
medulloblastoma cell line:D283 Med	10838-111E1	9.74	5.31	25.68	9.08	1.99	0.22	0.22	0.44
medulloblastoma cell line:ONS-76	10759-110E3	9.42	3.55	0.61	1.71	0.37	0.49	0.24	0.24
melanoma cell line:COLO 679	10514-107E1	4.31	2.73	3.02	3.45	1.15	0.29	0.57	0.00
melanoma cell line:G-361	10465-106H6	7.33	5.70	3.53	5.16	0.00	0.27	0.81	0.27
meningioma cell line:HKBMM	10691-109F7	7.78	3.62	4.16	2.35	0.90	0.00	0.36	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	0.88	1.76	26.43	13.22	0.88	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	4.15	2.33	15.29	7.52	5.96	0.26	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	8.13	1.69	1.69	1.38	1.38	0.31	0.61	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	5.45	2.36	1.64	2.36	0.55	0.18	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	6.63	1.66	1.24	2.48	0.83	0.41	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	7.45	2.95	2.25	0.98	0.42	0.00	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	6.74	3.08	2.12	1.35	1.93	0.00	0.19	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	14.58	2.78	2.08	2.08	1.39	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	15.10	7.38	1.20	2.23	0.34	0.34	0.00	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	11.96	5.64	1.61	1.61	1.27	0.58	0.69	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	6.50	2.92	4.38	2.39	1.99	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	9.18	3.78	2.70	4.05	1.76	0.14	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	12.38	5.98	5.83	4.55	2.13	0.85	1.00	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	24.37	12.84	2.31	1.65	2.31	5.27	1.32	3.29
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	6.09	3.46	4.84	3.87	1.38	0.42	0.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	12.92	3.84	3.49	4.19	2.09	1.05	1.05	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	6.12	1.43	2.65	2.65	0.82	0.00	1.22	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	11.50	5.75	2.88	2.88	1.80	2.16	1.44	1.44
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	11.90	4.34	2.69	3.00	1.55	1.14	1.24	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	29.41	16.87	0.91	1.82	1.60	23.26	1.82	3.42
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	14.68	5.03	1.26	4.20	2.10	2.10	1.26	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	14.20	6.13	3.89	3.14	1.79	0.30	0.30	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	9.89	4.46	4.55	2.80	0.96	1.40	1.58	0.61
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	36.45	13.62	4.42	3.31	1.47	1.10	0.74	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	18.31	8.01	4.86	4.01	2.00	3.15	1.43	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	2.53	0.84	1.26	1.26	1.26	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	7.31	2.28	0.91	1.37	0.46	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	5.12	1.79	1.02	1.02	1.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	4.45	2.36	1.57	0.79	1.31	0.26	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	6.16	1.54	1.23	1.54	1.23	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	6.35	2.82	0.94	1.18	0.94	0.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	3.72	1.02	1.35	1.02	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	11.00	0.79	0.79	0.79	1.57	0.39	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	5.10	2.78	2.78	1.39	1.39	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	7.50	3.46	3.46	2.02	1.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	4.46	2.01	1.56	1.12	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	8.89	0.96	1.68	0.72	1.92	0.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	10.27	2.20	6.60	5.13	2.20	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	6.04	2.35	1.68	1.34	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	5.32	1.23	1.64	2.05	1.64	0.00	0.41	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	5.15	1.72	1.29	1.29	0.43	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	0.00	10.33	10.33	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	4.55	2.27	3.25	0.97	2.92	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	7.27	4.36	2.91	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	4.26	3.73	2.13	0.53	0.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	4.91	0.82	4.09	0.82	4.91	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	5.44	1.17	1.94	1.55	1.55	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	6.30	2.10	0.00	2.10	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	9.93	0.99	0.99	1.99	2.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	0.00	9.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	2.37	2.96	2.96	2.96	2.37	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	7.31	2.44	1.22	3.66	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	4.43	3.80	4.43	3.80	5.07	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	6.90	3.10	4.83	2.07	3.10	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	6.45	0.00	2.15	0.00	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	0.00	3.99	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	3.44	13.78	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	4.48	1.22	2.04	0.00	1.63	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	5.56	3.18	3.18	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	6.48	4.72	1.77	1.18	0.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	5.61	1.87	1.25	1.56	0.94	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	8.02	2.67	4.01	0.00	2.67	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	7.10	1.18	2.37	2.37	1.18	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	0.00	2.57	2.57	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	4.13	2.75	0.69	2.75	2.07	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	3.96	2.47	2.97	1.48	0.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	2.24	3.36	0.00	2.24	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	2.54	0.64	0.64	3.18	0.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	2.42	2.82	2.82	4.03	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	4.36	0.00	0.00	4.36	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	1.27	2.53	1.27	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	4.86	1.21	4.25	3.64	0.61	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	4.52	9.04	9.04	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	3.29	1.65	3.29	2.47	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	3.17	1.98	0.99	2.38	1.19	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	3.24	2.92	0.32	2.27	1.95	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	4.07	2.04	1.02	2.04	1.02	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	7.74	1.55	3.09	5.42	0.77	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	11.81	7.09	2.83	6.61	1.42	0.24	1.18	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	54.44	34.98	15.75	5.33	29.19	19.23	3.94	7.41
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	4.27	0.00	8.55	0.00	0.00	4.27	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	5.45	4.73	2.67	1.34	2.77	2.06	1.23	1.13
mesothelioma cell line:Mero-25	10850-111F4	6.35	4.31	0.23	0.00	0.45	0.68	0.00	0.23
mesothelioma cell line:Mero-41	10851-111F5	7.33	3.18	3.18	2.44	2.20	0.73	0.49	0.73
mesothelioma cell line:Mero-48a	10852-111F6	5.54	1.77	1.55	1.11	1.77	1.77	1.11	0.22
mesothelioma cell line:Mero-82	10853-111F7	21.55	15.51	5.78	1.58	3.42	3.15	1.05	0.79
mesothelioma cell line:Mero-83	10854-111F8	7.66	4.26	3.40	0.85	1.53	0.17	1.36	0.51
mesothelioma cell line:Mero-84	10855-111F9	6.07	1.01	3.29	0.00	1.77	0.76	0.51	0.25
mesothelioma cell line:Mero-95	10856-111G1	22.98	15.11	3.52	1.24	1.45	3.73	1.66	1.66
mesothelioma cell line:NCI-H2052	10847-111F1	24.85	12.26	3.48	1.16	2.65	3.98	1.99	0.83
mesothelioma cell line:NCI-H226	10846-111E9	28.42	19.73	3.08	1.27	3.98	24.80	3.98	5.79
mesothelioma cell line:NCI-H2452	10848-111F2	16.74	13.49	6.83	1.88	5.64	2.90	2.05	1.54
mesothelioma cell line:NCI-H28	10845-111E8	10.94	5.34	12.72	3.56	39.19	7.38	4.58	3.31
mesothelioma cell line:No36	10857-111G2	11.42	4.89	3.26	0.65	0.98	0.33	0.98	1.30
mesothelioma cell line:ONE58	10858-111G3	10.03	7.04	2.98	1.35	0.54	1.90	0.81	1.08
migratory langerhans cells, donor1	11901-125F2	25.53	10.94	3.65	3.07	4.80	2.49	2.11	2.69
migratory langerhans cells, donor2	11902-125F3	15.26	5.25	3.05	3.54	2.08	1.47	2.20	2.44
migratory langerhans cells, donor3	11903-125F4	17.05	7.00	3.41	3.41	3.23	0.90	0.90	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	5.22	3.92	3.59	0.98	0.65	0.00	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	25.64	10.60	4.03	2.97	2.97	4.24	0.85	1.27
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	9.91	6.91	3.69	2.30	0.23	1.61	0.46	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	2.09	2.09	4.19	3.23	1.52	0.19	0.95	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	27.35	20.33	14.97	7.76	17.37	7.39	2.59	7.02
myeloma cell line:PCM6	10474-106I6	5.93	12.26	17.20	9.09	4.55	1.78	0.20	1.38
myxofibrosarcoma cell line:MFH-ino	10600-108E6	10.15	7.61	3.04	2.54	0.00	0.51	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	3.33	1.77	2.94	2.35	0.59	0.20	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	13.37	5.01	1.11	0.33	0.11	0.11	0.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	10.88	4.56	1.69	0.88	0.74	0.44	0.29	0.22
nasal epithelial cells, donor2	12227-129F4	13.25	5.52	2.76	1.10	1.10	1.66	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	0.46	0.23	2.76	4.14	1.15	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	3.18	1.50	18.90	15.15	4.86	0.00	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	36.06	33.95	24.04	6.54	16.45	4.01	1.90	3.59
neuroblastoma cell line:NH-12	10555-107I6	1.12	0.93	10.62	10.44	3.35	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	60.26	31.31	9.49	7.35	10.20	6.17	6.17	1.66
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	25.97	16.31	14.10	9.19	24.39	6.97	3.01	1.90
neuroectodermal tumor cell line:TASK1	10774-110F9	20.73	11.87	9.66	5.03	6.24	1.01	1.41	1.21
neuroepithelioma cell line:SK-N-MC	10728-110A8	23.52	13.99	0.00	1.27	0.00	0.64	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	11.45	5.06	1.86	1.60	0.53	0.00	0.27	0.00
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	74.37	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	53.12	26.56	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	9.47	28.41	9.47	18.94	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	34.50	30.61	31.12	12.68	22.83	2.54	5.92	2.71
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	3.20	0.80	4.80	4.80	0.80	0.00	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	1.60	0.96	4.81	0.96	0.64	0.00	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	7.62	3.68	5.26	1.58	1.58	0.53	0.26	0.26
nucleus accumbens, adult, pool1	10037-101F1	17.34	9.19	10.22	10.97	5.34	0.28	0.56	0.00
occipital cortex - adult, donor10196	10172-103C1	20.60	22.66	26.78	18.54	4.12	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	35.69	21.20	23.35	20.66	12.88	1.34	0.81	0.54
occipital cortex, newborn, donor10223	10355-105E4	10.55	5.82	6.55	4.00	5.46	0.73	0.73	0.36
occipital lobe, adult, donor1	10076-102A4	6.82	9.97	9.18	9.45	2.62	0.00	0.26	0.00
occipital lobe, fetal, donor1	10073-102A1	2.15	2.15	5.58	10.30	2.57	0.00	0.00	0.00
occipital pole, adult, pool1	10036-101E9	10.25	8.04	8.44	7.25	3.00	0.08	0.08	0.00
olfactory region, adult	10195-103E6	10.32	9.36	6.11	6.88	2.29	0.19	0.38	0.00
optic nerve, donor1	10277-104E7	34.02	16.01	22.01	32.02	2.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	7.75	4.90	6.72	1.03	1.14	3.87	2.96	3.53
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	10.72	5.08	0.27	0.00	0.14	0.41	0.27	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	7.79	4.23	2.54	0.68	0.68	1.19	1.86	0.85
oral squamous cell carcinoma cell line:SAS	10544-107H4	4.04	1.73	1.04	0.58	1.27	0.81	0.81	0.69
osteoclastoma cell line:Hs 706.T	10704-109H2	11.76	1.76	2.65	1.18	0.59	0.29	0.59	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	24.29	9.34	5.61	3.74	0.00	0.93	0.93	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	5.51	1.06	8.48	3.61	0.85	0.00	0.00	0.00
ovary, adult, pool1	10020-101D2	22.71	10.22	26.99	18.87	8.47	0.79	1.31	0.79
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	25.30	10.63	5.50	2.75	1.28	0.37	0.55	0.18
pancreas, adult, donor1	10049-101G4	28.22	18.81	31.04	16.93	1.88	4.70	2.82	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	1.68	1.68	0.00	0.00	0.28	0.84	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	21.12	19.25	4.43	1.70	6.13	3.75	2.21	1.53
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	36.59	11.59	9.93	2.48	3.81	9.44	5.30	4.31
paracentral gyrus, adult, pool1	10035-101E8	11.81	11.53	8.42	8.33	4.03	0.27	0.55	0.18
parietal cortex, adult, donor10258	10373-105G4	11.74	8.07	5.87	3.67	1.47	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	19.75	14.11	9.40	14.11	4.70	0.00	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	19.38	13.97	16.82	14.54	7.98	0.00	0.29	0.29
parietal lobe, adult, pool1	10034-101E7	12.51	9.61	11.98	9.34	3.17	0.00	0.62	0.09
parietal lobe, fetal, donor1	10072-101I9	4.85	2.91	3.88	6.79	1.94	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	11.22	4.11	7.48	6.36	7.48	1.87	0.75	0.37
parotid gland, adult	10199-103F1	20.35	23.43	26.52	6.17	1.85	1.23	5.55	0.62
penis, adult	10200-103F2	32.23	31.15	27.93	17.19	7.52	2.15	0.54	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	10.60	13.39	4.28	7.62	13.76	10.04	5.02	4.46
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	6.85	4.23	6.26	1.60	1.46	0.58	0.44	0.58
pineal gland - adult, donor10196	10179-103C8	43.86	12.90	78.69	31.61	2.58	1.29	1.94	0.65
pineal gland, adult, donor10252	10160-103A7	59.81	31.39	87.06	43.82	1.78	1.78	3.55	0.59
pineal gland, adult, donor10258	10377-105G8	24.46	11.29	45.15	16.93	2.51	0.63	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	29.34	14.17	51.60	10.12	4.05	2.02	2.02	0.00
pituitary gland, adult, donor10252	10162-103A9	57.85	30.75	124.56	29.71	7.82	2.08	1.56	0.52
pituitary gland, adult, donor10258	10378-105G9	16.17	7.66	53.63	9.36	5.96	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	418.51	242.31	12.69	6.13	3.55	65.79	21.18	17.09
plasma cell leukemia cell line:ARH-77	10840-111E3	5.69	5.16	5.96	2.65	10.86	2.12	1.99	1.19
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	12.14	8.72	14.32	4.67	2.49	2.18	3.11	1.25
pons, adult, pool1	10033-101E6	18.07	11.36	10.50	9.38	2.15	0.60	0.60	0.00
postcentral gyrus, adult, pool1	10032-101E5	10.98	8.54	8.54	7.93	2.88	0.26	0.35	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	89.93	25.10	16.73	23.01	10.46	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	5.51	11.02	0.00	11.02	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	10.78	5.97	4.22	1.60	0.58	1.17	2.48	0.73
prostate cancer cell line:PC-3	10439-106E7	10.89	3.81	4.36	1.63	1.63	1.63	1.27	1.82
prostate, adult, pool1	10022-101D4	37.36	18.68	23.22	14.06	5.89	3.63	2.72	4.63
putamen, adult, donor10196	10176-103C5	18.89	9.91	8.97	8.97	5.43	0.24	0.00	0.00
putamen, adult, donor10252	10152-102I8	41.18	7.84	5.88	11.76	5.88	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	48.08	12.02	1.09	5.46	2.19	1.09	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	7.49	5.32	3.62	4.35	1.93	0.24	0.48	0.00
putamen, newborn, donor10223	10365-105F5	11.24	6.00	2.25	10.50	5.25	0.75	2.25	1.50
rectal cancer cell line:TT1TKB	10469-106I1	19.20	9.60	6.11	1.45	1.16	5.24	0.87	3.20
rectum, fetal, donor1	10067-101I4	43.12	22.26	41.73	25.04	12.52	0.00	0.00	4.17
renal cell carcinoma cell line:OS-RC-2	10411-106B6	14.84	8.69	5.30	3.39	4.88	6.36	2.76	4.24
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	20.71	11.18	3.31	1.66	2.90	2.90	2.90	8.70
retina, adult, pool1	10030-101E3	38.96	23.96	120.17	37.57	6.96	0.60	1.69	0.30
retinoblastoma cell line:Y79	10475-106I7	26.24	18.45	60.53	19.74	5.98	0.52	2.60	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	2.58	1.72	3.69	3.07	1.11	0.25	0.37	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	22.78	15.75	39.93	9.84	6.19	0.56	0.28	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	18.19	6.06	7.58	2.27	0.76	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	28.65	12.46	5.66	0.81	0.32	4.21	1.62	1.29
salivary acinar cells, donor2	11772-123I8	16.80	9.09	9.23	1.65	1.10	0.83	1.24	0.28
salivary acinar cells, donor3	11773-123I9	43.70	20.52	26.48	2.65	0.66	0.66	0.66	1.32
salivary gland, adult, pool1	10093-102C3	23.45	21.73	30.31	8.01	1.72	3.43	2.29	1.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	4.38	2.95	2.53	1.60	0.76	0.08	0.00	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	2.47	1.88	2.00	2.23	0.82	0.12	0.35	0.00
seminal vesicle, adult	10201-103F3	49.20	35.98	41.80	21.16	8.47	1.59	3.17	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	9.96	5.34	4.37	1.46	1.46	0.97	2.43	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	9.31	6.79	3.27	1.51	0.75	1.51	0.50	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	9.03	7.02	3.01	2.01	1.00	2.01	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	19.88	13.03	4.30	3.76	3.36	2.82	1.34	1.07
signet ring carcinoma cell line:Kato III	10436-106E4	5.31	5.75	3.98	2.10	2.21	0.55	0.44	0.88
signet ring carcinoma cell line:NUGC-4	10483-107A6	16.00	9.68	3.74	1.94	3.48	1.29	1.03	0.77
skeletal muscle - soleus muscle, donor1	10282-104F3	64.55	114.91	153.22	29.79	7.80	4.26	0.00	2.84
skeletal muscle, adult, pool1	10023-101D5	67.04	83.48	99.79	23.75	12.71	4.68	1.20	2.88
skeletal muscle, fetal, donor1	10066-101I3	1.01	4.02	26.13	13.07	1.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	40.71	33.93	0.00	6.79	13.57	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	22.09	15.78	32.82	18.94	3.79	3.16	1.26	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	4.67	3.34	9.01	3.67	1.33	0.00	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	8.20	5.67	17.34	10.09	1.58	0.00	0.00	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	3.28	1.35	2.31	7.52	0.19	0.00	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	6.59	6.76	3.96	3.13	1.48	1.32	1.98	1.98
small cell lung carcinoma cell line:NCI-H82	10842-111E5	30.24	13.67	48.25	16.57	4.02	0.80	1.13	1.13
small cell lung carcinoma cell line:WA-hT	10562-108A4	5.01	3.05	17.43	7.63	1.96	1.09	1.74	0.00
small intestine, adult, pool1	10024-101D6	41.45	28.43	30.58	11.47	8.24	4.42	10.75	2.39
small intestine, fetal, donor1	10064-101I1	13.76	6.88	20.15	7.13	2.95	0.25	0.49	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	6.67	3.59	3.59	6.15	1.03	2.05	0.00	3.08
smooth muscle, adult, pool1	10048-101G3	29.98	20.16	31.01	13.96	3.36	1.55	1.29	0.26
somatostatinoma cell line:QGP-1	10781-110G7	11.26	10.99	6.97	5.63	0.00	1.07	2.41	1.34
spinal cord - adult, donor10196	10181-103D1	29.82	22.94	18.81	18.81	5.05	1.61	2.06	0.23
spinal cord, adult, donor10252	10159-103A6	42.98	24.44	17.35	14.98	4.34	0.00	1.58	0.00
spinal cord, adult, donor10258	10369-105F9	23.52	14.53	4.15	8.30	1.38	0.69	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	10.37	10.98	15.86	20.73	4.27	0.00	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	21.58	14.24	16.99	16.07	10.10	0.46	1.38	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	17.47	8.07	5.23	4.63	1.05	0.00	0.00	0.00
spleen, adult, pool1	10025-101D7	32.93	13.55	14.65	7.27	6.39	4.07	4.63	2.20
spleen, fetal, pool1	10044-101F8	42.11	17.24	31.62	18.20	11.84	6.20	5.56	2.22
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	8.90	4.97	7.56	4.55	5.28	4.45	3.73	4.66
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	5.89	3.42	5.89	1.71	0.57	0.95	1.90	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	16.42	14.68	16.07	8.74	1.75	0.35	1.75	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	19.16	8.60	8.99	3.13	3.13	1.56	1.17	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	18.01	8.44	15.65	6.42	4.73	3.04	5.07	3.38
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	5.51	1.27	0.85	1.27	0.42	0.00	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	25.38	19.46	4.23	2.96	1.69	4.23	2.12	2.12
stomach, fetal, donor1	10062-101H8	46.99	30.97	53.40	23.50	3.20	1.07	1.07	1.07
submaxillary gland, adult	10202-103F4	26.21	28.48	17.09	5.13	6.27	2.85	4.56	2.28
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	54.27	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	25.96	10.59	16.41	14.33	4.78	0.21	1.04	0.21
substantia nigra, adult, donor10258	10371-105G2	19.66	8.79	6.21	8.28	1.55	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	20.49	12.72	9.89	11.31	4.24	0.00	1.41	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	2.98	1.38	3.67	3.90	2.06	0.00	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	9.75	8.56	7.38	7.71	2.46	0.17	0.25	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	2.14	3.56	4.27	13.53	1.42	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	3.96	1.32	2.20	7.91	1.32	0.00	0.00	0.00
tenocyte, donor1	11763-123H8	10.82	4.19	1.40	2.44	0.70	0.00	0.00	0.35
tenocyte, donor2	11765-123I1	14.88	2.67	1.91	0.76	2.29	0.00	0.38	0.00
tenocyte, donor3	11768-123I4	6.67	1.48	0.74	0.74	1.48	0.37	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	24.47	20.91	6.12	3.06	1.36	5.10	1.87	5.44
teratocarcinoma cell line:NCR-G1	10798-110I6	11.10	7.86	14.49	4.16	0.92	0.15	0.15	0.77
teratocarcinoma cell line:PA-1	10807-111A6	17.67	15.81	4.34	4.96	2.32	2.48	2.63	4.49
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	21.33	16.38	10.03	3.94	2.79	7.74	3.55	5.33
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	48.41	26.85	15.13	13.61	7.19	15.88	6.81	20.42
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	21.49	13.52	29.01	14.51	6.65	11.12	1.31	8.94
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	63.51	29.31	10.10	3.58	5.54	18.57	3.91	23.78
testis, adult, pool1	10026-101D8	18.90	12.13	18.04	12.13	6.33	1.29	0.97	1.07
testis, adult, pool2	10096-102C6	20.30	17.14	13.53	13.53	4.96	0.45	0.45	0.00
thalamus - adult, donor10196	10168-103B6	29.81	13.25	11.04	11.04	3.31	1.10	1.10	0.00
thalamus, adult, donor10252	10154-103A1	25.47	16.72	15.32	17.35	8.60	0.47	1.72	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	49.27	10.78	3.08	6.16	1.54	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	10.38	6.26	5.27	4.61	1.65	0.16	0.49	0.00
thalamus, newborn, donor10223	10366-105F6	8.63	5.75	4.03	3.45	3.45	0.58	1.15	0.58
throat, adult	10209-103G2	35.45	46.69	39.45	15.48	11.73	3.00	5.24	0.25
throat, fetal, donor1	10061-101H7	28.34	20.42	46.01	24.38	8.84	0.61	2.13	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	7.95	5.37	2.98	6.16	5.96	0.20	0.79	0.40
thymus, adult, pool1	10027-101D9	38.27	32.01	4.18	5.96	18.49	1.89	6.06	1.99
thymus, fetal, pool1	10043-101F7	75.75	51.95	14.65	10.39	21.61	11.43	14.75	7.27
thyroid carcinoma cell line:KHM-5M	10776-110G2	8.64	7.31	1.60	1.73	0.93	1.99	1.99	1.33
thyroid carcinoma cell line:TCO-1	10783-110G9	14.25	12.85	6.43	2.93	4.19	1.68	2.10	0.56
thyroid, adult, pool1	10028-101E1	78.10	47.22	44.88	29.11	24.45	2.71	4.20	0.65
thyroid, fetal, donor1	10060-101H6	66.44	42.98	55.37	40.08	21.09	1.58	0.79	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	61.59	67.75	126.26	21.56	12.32	6.16	9.24	3.08
tongue, adult	10203-103F5	34.42	46.28	30.70	7.21	4.65	1.16	2.09	0.70
tongue, fetal, donor1	10059-101H5	34.29	37.04	30.35	7.49	1.58	0.39	0.00	0.00
tonsil, adult, pool1	10047-101G2	35.46	23.64	15.03	7.21	8.21	7.11	8.41	5.01
trachea, adult, pool1	10029-101E2	46.63	19.39	16.03	8.34	4.42	4.99	6.22	3.19
trachea, fetal, donor1	10058-101H4	24.24	15.00	27.70	9.62	5.77	1.92	2.31	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	6.38	3.54	3.54	4.61	2.13	0.71	1.06	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	7.40	5.17	3.24	1.52	1.72	1.42	1.52	1.93
transitional-cell carcinoma cell line:JMSU1	10492-107B6	23.19	9.71	8.15	4.86	2.98	4.54	4.07	3.13
tridermal teratoma cell line:HGRT	10694-109G1	11.42	1.90	1.90	9.51	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	8.72	6.18	2.37	1.27	1.10	0.85	1.35	1.02
umbilical cord, fetal, donor1	10057-101H3	18.78	2.09	31.30	2.09	4.17	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	69.28	30.20	49.82	37.03	10.92	6.31	2.22	5.46
uterus, fetal, donor1	10055-101H1	21.50	15.87	16.89	11.26	3.07	3.07	2.05	0.00
vagina, adult	10204-103F6	60.10	25.20	34.89	11.63	10.34	5.17	5.82	0.65
vein, adult	10191-103E2	25.65	12.71	15.56	12.06	12.28	1.53	2.19	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	4.54	4.54	5.61	1.87	5.61	4.01	2.67	4.81